	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S95-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S95-BMJ_2010_Apr_29_340_c1640	['maternal exposure and health of offspring\nthis report adds to other work SHOWING that maternal exposure to ambient ultraviolet radiation during Pregnancy MIGHT INFLUENCE subsequent health in the offspring.30313233in a new zealand Birth cohort, infants whose mothers were exposed to peak sunshine during the first Trimester were significantly heavier at Birth than infants whose mothers experienced trough levels of sunshine during the same trimester.30in the united kingdom, maternal ambient Ultraviolet B exposure in the third trimester HAS BEEN positively RELATED to bone Mineral density and content at age 9 in offspring.34there is now GROWING INTEREST in the ROLE of maternal Vitamin D deficiency in Pregnancy and the Development of Central Nervous System and Immune disorders, PARTICULARLY schizophrenia,33type 1 diabetes, and other disorders.35ALTHOUGH active Vitamin D3Concentrations in the mother increase substantially during Pregnancy, early fetal supplies are lower36and directly DEPENDENT on the mother.']	[('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 538), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 639), ('SUPERFICIAL_RELATIONSHIP', 663), ('IMPORTANT_CONSIDERATION', 782), ('ANOMALY_CURIOUS_FINDING', 848), ('SUPERFICIAL_RELATIONSHIP', 991)]	10	[('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0007567', 'parturition', 230, 'birth'), ('GO_0009294', 'DNA mediated transformation', 313, 'trimester'), ('GO_0007567', 'parturition', 353, 'birth'), ('CHEBI_72754', 'bisphenol AF', 492, 'ultraviolet B'), ('CHEBI_46662', 'mineral', 574, 'mineral'), ('CHEBI_27300', 'vitamin D', 680, 'vitamin D'), ('GO_0007565', 'female pregnancy', 704, 'pregnancy'), ('GO_0008289', 'lipid binding', 722, 'development'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 737, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 737, 'central nervous system'), ('UBERON_0002405', 'immune system', 764, 'immune'), ('PR_000017350', 'serine/threonine-protein kinase VRK2', 866, 'vitamin D3concentrations'), ('GO_0007565', 'female pregnancy', 935, 'pregnancy')]	0	['maternal exposure offspring\nthis maternal exposure ambient ultraviolet radiation pregnancy offspring.30313233in zealand birth cohort, infants whose mothers exposed peak sunshine trimester heavier birth infants whose mothers experienced trough levels sunshine trimester.30in united kingdom, maternal ambient ultraviolet b exposure third trimester positively bone mineral density content age 9 offspring.34there maternal  pregnancy central nervous system  disorders, schizophrenia,33type diabetes, disorders.35although vitamin d3concentrations mother increase pregnancy, fetal supplies lower36and mother.']
S99-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]	0	['ultraviolet radiation exposure trimester  concentrations trimester,  half life months.45in australian work, higher levels ambient ultraviolet radiation higher  concentrations population lag half months.46\n\npossible mechanisms\nfirst trimester  concentrations central nervous system embryonic development,  receptors expressed neuroepithelium subventricular zone.15myelination occurs later; mid-gestation (19-24 weeks) cortical axonal tracts myelinated,47with myelination occurring late 29-39 weeks.48in addition, utero  central tolerance occurs trimester  immunomodulating properties.']
S34-PMC2821652	PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]	0	['rickets main sequelae  deficiency, long-latency disease (such sclerosis [23–25], rheumatoid arthritis [26–29], type 2 diabetes [30–34], cardiovascular disease [35,36], cancers [37–43], systemic lupus erythematosus [44], name few) acute infections upper respiratory illnesses [45] tuberculosis [46,47]  alterations  [47–49].']
S139-PMC2963768	PMC2963768	10/2010	S139-PMC2963768	['the Vitamin D receptor HAS BEEN FOUND within VIRTUALLY every Organ-System (55), and the active Metabolite of Vitamin D is WELL-DESCRIBED as a potent mediator of Cell Proliferation and Differentiation, PARTICULARLY NOTED for its range of EFFECTS on Immune function in laboratory MODELS (56).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 45), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 214), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 278)]	8	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000062', 'organ', 61, 'organ'), ('UBERON_0000467', 'anatomical system', 67, 'system'), ('CHEBI_39382', 'flufenoxuron', 95, 'metabolite'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D'), ('GO_0030154', 'cell differentiation', 161, 'cell proliferation ... differentiation'), ('UBERON_0002405', 'immune system', 248, 'immune')]	0	[' receptor organ-system (55), metabolite  well-described potent cell proliferation differentiation,  laboratory (56).']
S16-PMC3004407	PMC3004407	12/2010	S16-PMC3004407	['RATHER, Vitamin D is now seen as a preprohormone whose active Metabolites act not only to ensure Calcium Homeostasis and bone health [5] but also act as mediators of Immune function in general [6,7], and specific to Pregnancy, play a ROLE in Immune tolerance, Insulin resistance, and Preeclampsia [8–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 234)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_25212', 'metabolite', 62, 'metabolites'), ('GO_0055073', 'cadmium ion homeostasis', 97, 'calcium homeostasis'), ('UBERON_0002405', 'immune system', 166, 'immune'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0002405', 'immune system', 242, 'immune'), ('PR_000045358', 'insulin family protein', 260, 'insulin'), ('GO_0007128', 'meiotic prophase I', 284, 'preeclampsia')]	0	['rather,  preprohormone whose metabolites ensure calcium homeostasis bone [5]  [6,7], pregnancy, play  tolerance, insulin resistance, preeclampsia [8–12].']
S156-PMC3004407	PMC3004407	12/2010	S156-PMC3004407	['given RECENT DISCOVERIES that LINK Vitamin D with the innate Immune System [6], it is not UNREASONABLE to predict that deficiencies during fetal development COULD have lasting sequelae on the child, NOT ONLY in terms of bone mineralization, BUT ALSO in terms of Immune Development that becomes the basis for later derangements SEEN with long-latency diseases such as multiple sclerosis, rheumatoid arthritis, diabetes, and certain cancers [59].']	[('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 13), ('SUPERFICIAL_RELATIONSHIP', 30), ('IMPORTANT_CONSIDERATION', 90), ('INCOMPLETE_EVIDENCE', 157), ('ANOMALY_CURIOUS_FINDING', 199), ('ANOMALY_CURIOUS_FINDING', 241), ('INCOMPLETE_EVIDENCE', 327)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007566', 'embryo implantation', 61, 'immune'), ('UBERON_0002405', 'immune system', 61, 'immune system'), ('GO_0001822', 'kidney development', 262, 'immune development'), ('UBERON_0002405', 'immune system', 262, 'immune')]	0	['given  innate  [6], fetal lasting sequelae child, terms bone mineralization, terms  becomes derangements long-latency diseases sclerosis, rheumatoid arthritis, diabetes, cancers [59].']
S159-PMC3004407	PMC3004407	12/2010	S159-PMC3004407	"['[""""TAKING INTO account Vitamin D\'s EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70].""""]']"	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]	0	"['[""""taking accoun d*s une maintenance throughout n maintaining health, least, women n counseled regarding n offspring therapy ensun [60–62,68–70].""""]']"
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]	0	['introduction\nmultiple sclerosis (ms) chronic autoimmune etiology demyelinative inflammatory physiopathology axonal damages.12this disease females males ordinary 10 relapsing-remitting course secondary progressive phase.2on histological basis, helper cells type (th1) pathologies ms.1–3there ms genetic ones environmental exact ms yet.45from environmental ms, infection ebv, smoking serum  favorable.67the vitamin calcium phosphor homeostasis . vitamin .48this achieved via phagocytic monocytes9and decreasing secretion il-6, il-12, tnf-α pge2 monocytes.10also, immature semi mature apc’s mature presence 1,25 (oh)2d.8many paracrine nerve synthesis  cns also, vitamin pregnancy period neural system disorder animal cases.811–14then,  ms results follows: first, latitude via exposure sun serum  ms prevalence, distance equator, norway.23815second, vander et al.']
S57-PMC3075531	PMC3075531	7/2010	S57-PMC3075531	['furthermore, Genetic variations in Vitamin-D-related and other Genes MIGHT INFLUENCE the EFFECTS of Vitamin D on the Immune System.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('SO_0000704', 'gene', 13, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 35, 'vitamin-D'), ('SO_0000704', 'gene', 63, 'genes'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune system')]	0	['furthermore, genetic vitamin-d-related genes  .']
S103-PMC3235789	PMC3235789	12/2011	S103-PMC3235789	['the active form of Vitamin D (1,25-Dihydroxyvitamin D3) is a key modulator of the Immune Response, and Vitamin D is KNOWN to be a potent regulator of Placental Immunity, stimulating Antimicrobial Responses while suppressing inflammation [39].']	[('INCOMPLETE_EVIDENCE', 116)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 30, '1,25-dihydroxyvitamin D3'), ('GO_0006955', 'immune response', 82, 'immune response'), ('UBERON_0002405', 'immune system', 82, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0001987', 'placenta', 150, 'placental'), ('GO_0007566', 'embryo implantation', 160, 'immunity'), ('CHEBI_65381', 'albizoside C', 182, 'antimicrobial'), ('GO_0051607', 'defense response to virus', 182, 'antimicrobial responses')]	0	['form  (1,25-dihydroxyvitamin d3) modulator  response,  potent placental immunity, antimicrobial responses suppressing inflammation [39].']
S1-PMC3277098	PMC3277098	12/2011	S1-PMC3277098	['abstract\na ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 77)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 37, 'regulation of immune'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_28384', 'vitamin K', 114, 'Vitamin D'), ('CL_0000542', 'lymphocyte', 137, 'lymphocytes')]	0	['abstract\na   vitamin receptors lymphocytes.']
S4-PMC3277098	PMC3277098	12/2011	S4-PMC3277098	['THIS REVIEW explores the FINDINGS of epidemiological, clinical and laboratory research, and the POTENTIAL ROLE of Vitamin D in promoting the inappropriate Immune Responses which UNDERPIN the rise in a broad range of Immune diseases.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 178)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006955', 'immune response', 155, 'immune responses'), ('UBERON_0002405', 'immune system', 155, 'immune'), ('UBERON_0002405', 'immune system', 216, 'immune')]	0	['epidemiological, laboratory research,  promoting  responses rise broad  diseases.']
S8-PMC3277098	PMC3277098	12/2011	S8-PMC3277098	['we now KNOW that all Tissues in the body posses receptors for the active form of Vitamin D, 1,25-Dihydroxyvitamin D (1α,25(Oh)2D3) and it HAS RECENTLY BEEN DISCOVERED that there are Extrarenal Tissues capable of converting 25(Oh)D to the active Metabolite, including certain Immune Cells [1,2].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 156)]	3	[('UBERON_0000479', 'tissue', 21, 'tissues'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 92, '1,25-dihydroxyvitamin D'), ('CHEBI_34898', 'OM-174', 123, 'OH)2D3'), ('UBERON_0005292', 'extraembryonic tissue', 182, 'extrarenal tissues'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 245, 'metabolite'), ('CL_0000738', 'leukocyte', 275, 'immune cells'), ('UBERON_0002405', 'immune system', 275, 'immune')]	0	['tissues posses receptors form 1,25-dihydroxyvitamin (1α,25(oh)2d3) extrarenal tissues capable converting 25(oh)d metabolite,  cells [1,2].']
S10-PMC3277098	PMC3277098	12/2011	S10-PMC3277098	['it is this ASSOCIATION with Immune and Airway function that provides the basis for the HYPOTHESIS that Vitamin D MAY have direct LINKS with asthma and allergic disease [6,7].']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001005', 'respiratory airway', 39, 'airway'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]	0	[' airway  asthma allergic disease [6,7].']
S11-PMC3277098	PMC3277098	12/2011	S11-PMC3277098	['we AIM to review the CURRENT EVIDENCE on Vitamin D in RELATION to Immune mechanisms and FOCUS on the EFFECT of Pregnancy and Early Life exposure on Allergy Development.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 101)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0002405', 'immune system', 66, 'immune'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('UBERON_0001847', 'lobule of pinna', 125, 'early life'), ('GO_0060021', 'roof of mouth development', 148, 'allergy development')]	0	['  mechanisms pregnancy life exposure allergy development.']
S35-PMC3277098	PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]	0	[' status utero life  allergic disease.']
S38-PMC3277098	PMC3277098	12/2011	S38-PMC3277098	['Immune Cell Differentiation and Proliferation\nthe ROLE of Vitamin D in Regulation Of the Immune System was FIRST RECOGNIZED through the identification of Vitamin D receptors on Peripheral Blood Mononuclear cells (Lymphocytes) [2].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 107), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CL_0000902', 'induced T-regulatory cell', 0, 'Immune Cell'), ('GO_0002121', 'inter-male aggressive behavior', 0, 'Immune Cell Differentiation ... Proliferation'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007093', 'mitotic cell cycle checkpoint signaling', 71, 'regulation of ... immune system'), ('UBERON_0002405', 'immune system', 89, 'immune system'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('UBERON_0012101', 'perinatal stage', 177, 'peripheral blood'), ('CL_0000100', 'motor neuron', 194, 'mononuclear'), ('GO_0031097', 'medial cortex', 194, 'mononuclear'), ('CL_0000542', 'lymphocyte', 213, 'lymphocytes')]	0	['immune cell proliferation\nthe   vitamin receptors peripheral blood mononuclear cells (lymphocytes) [2].']
S57-PMC3277098	PMC3277098	12/2011	S57-PMC3277098	['weiss [33] PROPOSES in his editorial on Vitamin D and the Gut microbiome that Vitamin D COULD POTENTIALLY INTERACT directly with both the galt and the microflora, to INFLUENCE Immune function and allergy outcomes, a THEORY also explored by vassallo and camargo [35].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 106), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 216)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 58, 'gut'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 176, 'immune')]	0	['weiss [33] editorial  gut microbiome  galt microflora,  allergy outcomes, vassallo camargo [35].']
S140-PMC3277098	PMC3277098	12/2011	S140-PMC3277098	['Cord Blood (Cb) HAS BEEN used as a measure of fetal Vitamin D status at Birth in the investigation of Immune function and allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 12, 'CB'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007567', 'parturition', 72, 'birth'), ('UBERON_0002405', 'immune system', 102, 'immune')]	0	['cord blood (cb) measure fetal  status birth  allergic outcomes.']
S201-PMC3277098	PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]	0	['future sources  genetic immunological changing vitamin status supplementation lifestyle changes.']
S204-PMC3277098	PMC3277098	12/2011	S204-PMC3277098	['there is MUCH EVIDENCE to SHOW Vitamin D AFFECTS Differentiation and Proliferation Of Immune Cells [2,24,25] and that Genetic polymorphisms, including of vdr and Vdbp , MAY CONTRIBUTE to disease susceptibility [42,78,79,80,81].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 169), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 49, 'differentiation ...'), ('GO_0008283', 'cell proliferation', 69, 'proliferation of ... cells'), ('CL_0000738', 'leukocyte', 86, 'immune cells'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('SO_0000704', 'gene', 118, 'genetic'), ('PR_000017279', 'testis-specific basic protein Y 1', 162, 'VDBP')]	0	[' proliferation  cells [2,24,25] genetic polymorphisms, vdr vdbp disease [42,78,79,80,81].']
S205-PMC3277098	PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]	0	['life programming   status levels.']
S207-PMC3277098	PMC3277098	12/2011	S207-PMC3277098	['RANDOMIZED control TRIALS are ultimately REQUIRED to determine the EFFECTS of Vitamin D supplementation on the developing Immune System, and any POTENTIAL ROLE in preventing allergic disease.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 41), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 155)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune system')]	0	['randomized  supplementation allergic disease.']
S54-PMC3347028	PMC3347028	3/2012	S54-PMC3347028	['it APPEARS that the Extrarenal function of Vitamin D has more to do with Immune function than with Calcium Metabolism and Homeostasis.']	[('ANOMALY_CURIOUS_FINDING', 3)]	1	[('UBERON_0001691', 'external ear', 20, 'extrarenal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0002405', 'immune system', 73, 'immune'), ('GO_0018884', 'carbazole metabolic process', 99, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 122, 'homeostasis')]	0	['extrarenal   calcium metabolism homeostasis.']
S58-PMC3347028	PMC3347028	3/2012	S58-PMC3347028	['DESPITE these OBSERVATIONS, it was CONCLUDED that the condition of Vitamin D deficiency LED TO weakness and malnutrition and was not a direct EFFECT of Vitamin D on the Immune System.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune system')]	0	['despite observations, condition  malnutrition  .']
S61-PMC3347028	PMC3347028	3/2012	S61-PMC3347028	['focusing on the innate Immune System first, a MAJOR mechanism of action of Vitamin D is via an endogenous Antimicrobial peptide called Cathelicidin (Ll-37), which is generated in response to Microbial Invasion through activation of toll-2 receptors (tlr) on Monocytes and Macrophages [19,20,21].']	[('IMPORTANT_CONSIDERATION', 46)]	1	[('GO_0007566', 'embryo implantation', 23, 'immune'), ('UBERON_0002405', 'immune system', 23, 'immune system'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 106, 'antimicrobial'), ('PR_000006009', 'alpha-catulin', 135, 'cathelicidin'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 149, 'LL-37'), ('GO_0000266', 'mitochondrial fission', 191, 'microbial invasion'), ('NCBITaxon_10088', 'Mus <genus>', 191, 'microbial'), ('CL_0000576', 'monocyte', 258, 'monocytes'), ('CL_0000235', 'macrophage', 272, 'macrophages')]	0	['focusing innate  first,  via endogenous antimicrobial peptide cathelicidin (ll-37), generated response microbial invasion activation toll-2 receptors (tlr) monocytes macrophages [19,20,21].']
S65-PMC3347028	PMC3347028	3/2012	S65-PMC3347028	['significant SUPPORT for the ROLE of Vitamin D in Immune Processes and function came in 2006 when liu et al.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0002252', 'immune effector process', 49, 'immune processes'), ('UBERON_0002405', 'immune system', 49, 'immune')]	0	['significant   processes came 2006 liu et al.']
S79-PMC3347028	PMC3347028	3/2012	S79-PMC3347028	['additionally, the ROLE of Vitamin D in Immune function intensifies the NEED to establish Vitamin D sufficiency during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 71)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 39, 'immune'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]	0	['additionally,   intensifies  pregnancy.']
S110-PMC3347028	PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]	0	['addition, rickets osteoporosis data, bone health, renal production 1,25(oh)2d calcium metabolism levels circulating  concentrations  function, delivery 25(oh)d cells tissue.']
S146-PMC3347028	PMC3347028	3/2012	S146-PMC3347028	['such readily observable fetal and neonatal Skeletal EFFECTS of profound Vitamin D deficiency are easily understood in terms of cause and effect, BUT the more subtle EFFECTS of deficiency on the developing Immune System, for example, and subsequent infection risk or Immune dysfunction are more DIFFICULT to understand [19,84,97,98,99].']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('SUPERFICIAL_RELATIONSHIP', 165), ('DIFFICULT_TASK', 294)]	4	[('UBERON_0004288', 'skeleton', 43, 'skeletal'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0002405', 'immune system', 205, 'immune system'), ('UBERON_0002405', 'immune system', 266, 'immune')]	0	['fetal neonatal skeletal  terms effect, subtle example, infection  dysfunction [19,84,97,98,99].']
S163-PMC3347028	PMC3347028	3/2012	S163-PMC3347028	['WHILE we await the results of numerous clinical trials now underway TO determine IF there is a discernible EFFECT of Vitamin D in altering RISK for various disease states to understand the ROLE of Vitamin D in health, it is IMPORTANT not TO discount the MOUNTING EVIDENCE from laboratory studies and prospective observation trials [103,104,105] that Vitamin D—as a preprohormone—is ESSENTIAL in maintaining the Immune System with PROFOUND IMPLICATIONS [19,138,139,140].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 189), ('IMPORTANT_CONSIDERATION', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 238), ('INCOMPLETE_EVIDENCE', 254), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 430), ('IMPORTANT_CONSIDERATION', 439)]	12	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 350, 'vitamin D'), ('UBERON_0002405', 'immune system', 411, 'immune system')]	0	['results discernible  altering disease  health, laboratory [103,104,105] —as preprohormone—is maintaining  [19,138,139,140].']
S232-PMC3347028	PMC3347028	3/2012	S232-PMC3347028	['WHAT about Vitamin D’s ROLE in maintaining Immune Homeostasis during Pregnancy?']	[('EXPLICIT_QUESTION', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 43, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 43, 'immune'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy')]	0	['’s maintaining  homeostasis pregnancy?']
S238-PMC3347028	PMC3347028	3/2012	S238-PMC3347028	['in the last five years, there has been an explosion of published data concerning the Immune EFFECTS of Vitamin D, YET LITTLE IS KNOWN in this regard about the specific Immune EFFECTS of Vitamin D during Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('ANOMALY_CURIOUS_FINDING', 114), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('UBERON_0002405', 'immune system', 85, 'immune'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 168, 'immune'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]	0	['last five years, explosion  regard   pregnancy.']
S0-PMC3348565	PMC3348565	4/2012	S0-PMC3348565	['EFFECT on the incidence of pneumonia of Vitamin D supplementation by quarterly bolus dose to infants in kabul: a randomised controlled superiority trial\n\nabstractsummary\n\nbackground\nVitamin D has a ROLE in Regulating Immune function, and its deficiency is a SUGGESTED risk factor for childhood pneumonia.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 258)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 182, 'Vitamin D'), ('GO_0065007', 'biological regulation', 206, 'regulating'), ('UBERON_0002405', 'immune system', 217, 'immune')]	0	['effect pneumonia  supplementation quarterly bolus dose infants kabul: randomised superiority trial\n\nabstractsummary\n\nbackground\nvitamin  function, childhood pneumonia.']
S121-PMC3348565	PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]	0	['although true, serum concentrations immunological  higher skeletal system concentrations.6the steady vitamin d2supplementation cancer22and bone outcomes.23\nour case-control hospital rate  rickets children pneumonia calcitriol, biologically metabolite human .4a  supplementation infectious diseases findings, rigorously (panel).25no  radiologically pneumonias.']
S115-PMC3365381	PMC3365381	3/2011	S115-PMC3365381	['Imprinting with receptor level acting Vitamins A and D INFLUENCED the Brain biogenic amine levels of f1 progenies (tekes et al.2009a,b,c) as well as the hormone Production Of Immune Cells (csaba et al.2007).']	[('SUPERFICIAL_RELATIONSHIP', 55)]	1	[('GO_0071514', 'genetic imprinting', 0, 'Imprinting'), ('CHEBI_27300', 'vitamin D', 38, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 47, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 53, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 53, 'D'), ('UBERON_0000955', 'brain', 70, 'brain'), ('GO_0002001', 'renin secretion into blood stream', 161, 'production of immune cells'), ('CL_0000738', 'leukocyte', 175, 'immune cells'), ('UBERON_0002405', 'immune system', 175, 'immune')]	0	['imprinting receptor  brain biogenic amine levels f1 progenies (tekes et al.2009a,b,c) hormone production  cells (csaba et al.2007).']
S0-PMC3395583	PMC3395583	7/2012	S0-PMC3395583	['month of Birth, Vitamin D and risk of Immune-mediated disease: a case control study\n\nabstract\n\nbackground\na season of Birth EFFECT in Immune-mediated diseases (id) such as multiple sclerosis and type 1 diabetes HAS BEEN CONSISTENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 220), ('INCOMPLETE_EVIDENCE', 233)]	4	[('GO_0007567', 'parturition', 9, 'birth'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0002405', 'immune system', 134, 'immune')]	0	['month birth,  -mediated disease: study\n\nabstract\n\nbackground\na season birth -mediated diseases (id) sclerosis type diabetes reported.']
S21-PMC3395583	PMC3395583	7/2012	S21-PMC3395583	['DESPITE these DIFFERENCES, an abnormal Activation Of the Immune System is a common thread LINKING these conditions and several OBSERVATIONS INDICATE that similar Genetic pathways and environmental agents, such as Vitamin D deficiency, smoking behaviour and various infections, are INVOLVED in the pathogenesis of these disorders [18-20,22-25].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 281)]	7	[('GO_0000103', 'sulfate assimilation', 39, 'activation of ... immune system'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('SO_0000704', 'gene', 162, 'genetic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]	0	['despite differences, abnormal activation  thread conditions genetic environmental agents,  deficiency, smoking behaviour infections, pathogenesis disorders [18-20,22-25].']
S89-PMC3395583	PMC3395583	7/2012	S89-PMC3395583	['furthermore, in utero Vitamin D deficiency has a significant EFFECT on the developing Immune System and our group has RECENTLY SHOWN that Genes ASSOCIATED with ms, ra, cd, sle and t1d are significantly enriched for Vitamin D receptor Binding Sites [44-46].']	[('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('SO_0000704', 'gene', 138, 'genes'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 223, 'D'), ('SO_0000409', 'binding_site', 234, 'binding sites')]	0	['furthermore, utero   genes ms, ra, cd, sle t1d enriched  receptor binding sites [44-46].']
S82-PMC3407995	PMC3407995	7/2012	S82-PMC3407995	['the MAJORITY of circulating Vitamin D, known as Serum 25-Hydroxyvitamin D [25(Oh)D] that is NECESSARY to maintain health and function of the Immune, Reproductive, Muscular, Skeletal and Integumentary System, originates from Vitamin D3 (Cholecalciferol) and REFLECTS endogenous synthesis from exposure to sunlight as well as Intake from the diet [46].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 92), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0002405', 'immune system', 141, 'immune ...'), ('GO_0000003', 'reproduction', 149, 'reproductive'), ('UBERON_0022230', 'retrohippocampal region', 149, 'reproductive ...'), ('UBERON_0004469', 'musculature of back', 163, 'muscular ...'), ('UBERON_0004288', 'skeleton', 173, 'skeletal'), ('UBERON_0002416', 'integumental system', 186, 'integumentary system'), ('CHEBI_33279', 'vitamin D5', 224, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 224, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 236, 'cholecalciferol'), ('GO_0007631', 'feeding behavior', 324, 'intake')]	0	['circulating serum 25-hydroxyvitamin [25(oh)d] maintain reproductive, muscular, skeletal integumentary system, originates vitamin d3 (cholecalciferol) endogenous synthesis exposure sunlight intake diet [46].']
S258-PMC3407995	PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]	0	['maternal  status pregnancy maternal, foetal postnatal outcomes maternal  status, pregnancy, pregnancy sustaining foetal growth, composition, skeletal development,  maturation respiratory [141].']
S14-PMC3427192	PMC3427192	4/2012	S14-PMC3427192	['Vitamin D overview\nVitamin D, a fat-soluble Nutrient, is a Secosteroid Hormone which is widely recognized as a modulator of calcium absorption and bone health and further Regulates Neuromuscular function, Cellular Differentiation, Insulin secretion, and Blood pressure.25,26vitamin D also plays an IMPORTANT ROLE in Immune Regulation through interactions between 1,25-Dihydroxyvitamin D and Vitamin D receptors ( vdrs ) .']	[('IMPORTANT_CONSIDERATION', 298), ('SUPERFICIAL_RELATIONSHIP', 308)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 44, 'nutrient'), ('CHEBI_26661', 'shidasterone', 59, 'secosteroid hormone'), ('GO_0065007', 'biological regulation', 171, 'regulates'), ('UBERON_0001016', 'nervous system', 181, 'neuromuscular'), ('GO_0030154', 'cell differentiation', 205, 'cellular differentiation'), ('PR_000045358', 'insulin family protein', 231, 'insulin'), ('UBERON_0000178', 'blood', 254, 'blood'), ('PR_000006444', 'diacylglycerol kinase delta', 282, 'D'), ('UBERON_0002405', 'immune system', 316, 'immune'), ('GO_0065007', 'biological regulation', 323, 'regulation'), ('CHEBI_67472', '15-epi-lupulin B', 363, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D')]	0	['vitamin overview\nvitamin d, fat-soluble nutrient, secosteroid hormone modulator calcium absorption bone neuromuscular function, cellular differentiation, insulin secretion, blood pressure.25,26vitamin plays  1,25-dihydroxyvitamin  receptors vdrs .']
S15-PMC3427192	PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]	0	['vdrs expressed airway  cells, nuclear steroid hormone receptors regulate transcription genes inflammation immunomodulation.27vitamin plays respiratory infection facilitating toll-like receptor signaling synthesis human cathelicidin antimicrobial peptide,28-30which cleaved generate cationic peptide, ll-37.31,32vitamin exerts cells gene transcription33and airway inflammatory disorders.34while  suppress il-1735and il-4-mediated expression il-13,35,36it th1/th2 balance toward th2 dominance.37these actions  cd4+t cells il-10-secreting t-regulatory population.38\n\nbiosynthesis \nbiosynthesis  begins absorption solar ultravoilet-b (uvb) radiation secondarily via consumption -rich fortified foods, oily fish, fortified grains dairy products.26following exposure uvb radiation, 7-dehydrocholesterol skin converted previtamin d3( fig.']
S32-PMC3427192	PMC3427192	4/2012	S32-PMC3427192	['HOWEVER, in THESE STUDIES, there were no associations between Cord-Blood 25(Oh)D concentrations and subsequent asthma at 5 y of age.59,66\ncollectively, these studies SUGGEST that the benefits of Vitamin D during early Life MAY BE LIMITED to its EFFECTS on Respiratory infections and Viral-induced wheezing and not asthma per se.17HOWEVER, ALTHOUGH Vitamin D MAY have IMPORTANT ROLES in Immune Regulation during early Life, excessive Vitamin D exposure MAY also be ASSOCIATED with adverse health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 166), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 230), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 328), ('ANOMALY_CURIOUS_FINDING', 339), ('INCOMPLETE_EVIDENCE', 358), ('IMPORTANT_CONSIDERATION', 367), ('SUPERFICIAL_RELATIONSHIP', 377), ('INCOMPLETE_EVIDENCE', 452), ('SUPERFICIAL_RELATIONSHIP', 464)]	13	[('UBERON_0002240', 'spinal cord', 62, 'cord'), ('UBERON_0000178', 'blood', 67, 'blood'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('UBERON_0000104', 'life cycle', 218, 'life'), ('UBERON_0001004', 'respiratory system', 256, 'respiratory'), ('NCBITaxon_1', 'root', 283, 'viral'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0002521', 'leukocyte differentiation', 386, 'immune regulation'), ('UBERON_0002405', 'immune system', 386, 'immune'), ('UBERON_0000104', 'life cycle', 417, 'life'), ('CHEBI_27300', 'vitamin D', 433, 'vitamin D')]	0	['however, studies, cord-blood 25(oh)d concentrations asthma 5 age.59,66\ncollectively,  life respiratory infections viral-induced wheezing asthma se.17however,   life, excessive  exposure outcomes.']
S22-PMC3472720	PMC3472720	8/2012	S22-PMC3472720	['we wondered IF the second generation (f2) had any persisting alterations in Immune function RELATED to the Vitamin D status of the Pregnant f0female Mice.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('UBERON_0002405', 'immune system', 76, 'immune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice')]	0	['generation (f2) persisting alterations   status pregnant f0female mice.']
S53-PMC3472720	PMC3472720	8/2012	S53-PMC3472720	['NONETHELESS, to date, NOT a single study has yet DEMONSTRATED a Pirna- or a Mirna-ASSOCIATED action of Vitamin D on the Immune or the Nervous system.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('SO_0001035', 'piRNA', 64, 'piRNA'), ('SO_0000276', 'miRNA', 76, 'miRNA'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('UBERON_0001016', 'nervous system', 134, 'nervous')]	0	['nonetheless, date, single pirna- mirna-associated   nervous system.']
S69-PMC3472720	PMC3472720	8/2012	S69-PMC3472720	['it is THEREFORE LIKELY that his/her Immune and Nervous Systems BENEFITED from Vitamin D’s WELL-DESCRIBED anti-inflammatory actions [23].']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 16), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 90), ('INCOMPLETE_EVIDENCE', 95)]	5	[('UBERON_0002405', 'immune system', 36, 'immune'), ('UBERON_0001016', 'nervous system', 47, 'nervous systems'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]	0	['his/her  nervous systems ’s well-described anti-inflammatory [23].']
S105-PMC3472720	PMC3472720	8/2012	S105-PMC3472720	['conclusions\nwe SHOW HERE for the FIRST TIME that a maternal Vitamin D deficiency induces inverted transgenerational EFFECTS on the Immune System of offspring: the f2generation is more sensitive to Myelin peptide immunization WHILE, as PREVIOUSLY DEMONSTRATED, the f1generation is less sensitive.']	[('INCOMPLETE_EVIDENCE', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('INCOMPLETE_EVIDENCE', 235)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune system'), ('UBERON_0000345', 'myelin', 197, 'myelin')]	0	['conclusions\nwe maternal  inverted transgenerational  offspring: f2generation sensitive myelin peptide immunization while, demonstrated, f1generation sensitive.']
S19-PMC3476426	PMC3476426	8/2012	S19-PMC3476426	['a ROLE for Vitamin D in the Regulation Of Immune function was FIRST PROPOSED after the identification of Vitamin D receptors in Lymphocytes.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 68)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0006883', 'cellular sodium ion homeostasis', 28, 'regulation of immune'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CL_0000542', 'lymphocyte', 128, 'lymphocytes')]	0	['   receptors lymphocytes.']
S21-PMC3476426	PMC3476426	8/2012	S21-PMC3476426	['there is a GROWING BODY of LITERATURE LINKING Vitamin D to various Immune-related conditions, including allergy and autoimmunity [4].']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune')]	0	[' -related conditions, allergy autoimmunity [4].']
S108-PMC3476426	PMC3476426	8/2012	S108-PMC3476426	['maternal Vitamin D deficiency MAY BE a risk factor for autism, POSSIBLY by AFFECTING fetal Brain Development as well as by AFFECTING maternal Immune System status during Pregnancy [37,38].']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 123)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007420', 'brain development', 91, 'brain development'), ('UBERON_0000955', 'brain', 91, 'brain'), ('UBERON_0002405', 'immune system', 142, 'immune system'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]	0	['maternal  autism, fetal brain maternal  status pregnancy [37,38].']
S16-PMC3501517	PMC3501517	11/2012	S16-PMC3501517	['the POTENTIAL ROLE of Vitamin D on Immune function HAS BEEN explored in the last decade.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 35, 'immune')]	0	['  last decade.']
S314-PMC3613945	PMC3613945	2/2013	S314-PMC3613945	['conclusion\nthere is GROWING EVIDENCE that dbp plays a ROLE in Immune modulation, EITHER directly through gc-maf, OR indirectly by INFLUENCING Serum levels of Vitamin D. it is TEMPTING to SPECULATE that dbp operates as a molecular switch between pro- and anti-inflammation and intervention STRATEGIES designed to modify this switch MAY be IMPORTANT in the Control and prevention Of chronic and Infectious Diseases.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 187), ('FUTURE_WORK', 289), ('INCOMPLETE_EVIDENCE', 331), ('IMPORTANT_CONSIDERATION', 338)]	9	[('UBERON_0002405', 'immune system', 62, 'immune'), ('UBERON_0001977', 'blood serum', 142, 'serum'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0001715', 'ectodermal cell fate specification', 355, 'control ... of ... infectious diseases')]	0	['conclusion\nthere dbp plays  modulation, serum levels . dbp operates molecular switch pro- anti-inflammation switch chronic infectious diseases.']
S41-PMC3635901	PMC3635901	4/2013	S41-PMC3635901	['finally, because (no-longer-just-a-)Vitamin D has several physiological properties INVOLVED with the Innate Immune Defense Against Tb, the ROLE of this Vitamin in the treatment of tb SHOULD BE evaluated, especially when ASSOCIATED with autoimmunity [18].']	[('SUPERFICIAL_RELATIONSHIP', 83), ('SUPERFICIAL_RELATIONSHIP', 139), ('FUTURE_WORK', 183), ('SUPERFICIAL_RELATIONSHIP', 220)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0048017', 'inositol lipid-mediated signaling', 101, 'innate immune defense against TB'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('CHEBI_33229', 'vitamin (role)', 152, 'vitamin')]	0	['finally, (no-longer-just-a-) physiological properties innate  defense tb, vitamin treatment tb evaluated, autoimmunity [18].']
S118-PMC3659910	PMC3659910	1/2013	S118-PMC3659910	['nutritional Vitamin D status has very RECENTLY been LINKED to the Human innate Immune System and its ability to contain mycobacterium tuberculosis.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('GO_0007566', 'embryo implantation', 79, 'immune'), ('UBERON_0002405', 'immune system', 79, 'immune system')]	0	['nutritional  status human innate  ability contain mycobacterium tuberculosis.']
S194-PMC3659910	PMC3659910	1/2013	S194-PMC3659910	"['[\'FUTURE STUDIES are ESSENTIAL to determine the true Vitamin D REQUIREMENT during Pregnancy NOT ONLY for maternal Skeletal preservation and fetal Skeletal Formation, BUT ALSO for fetal “Imprinting"""" that MAY AFFECT Neurodevelopment, Immune function and chronic disease SUSCEPTIBILITY soon after Birth as well as later in Life.\']']"	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 90), ('FUTURE_PREDICTION', 201), ('SUPERFICIAL_RELATIONSHIP', 205), ('IMPORTANT_CONSIDERATION', 266)]	7	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('UBERON_0004288', 'skeleton', 112, 'skeletal'), ('GO_0001501', 'skeletal system development', 144, 'skeletal formation'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('GO_0071514', 'genetic imprinting', 184, 'imprinting'), ('GO_0007399', 'nervous system development', 212, 'neurodevelopment'), ('UBERON_0002405', 'immune system', 230, 'immune'), ('GO_0007567', 'parturition', 292, 'birth'), ('UBERON_0000104', 'life cycle', 318, 'life')]	0	"['[*future tru pregnancy maternal skeletal preservation fetal skeletal formation, fetal “imprinting"""" neurodevelopmenune chronic disease soon birth life.*]']"
S42-PMC3672018	PMC3672018	5/2013	S42-PMC3672018	['furthermore, there are studies SHOWING that low fetal Vitamin D MAY lead to persistent changes in the Immune System, THUS POSSIBLY INFLUENCING the risk of developing Autoimmune diseases such as t1d [14,19,20].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 102, 'immune system'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune')]	0	['furthermore, fetal  changes autoimmune diseases t1d [14,19,20].']
S17-PMC3685533	PMC3685533	6/2013	S17-PMC3685533	['moreover, Vitamin D is a modulator of the Innate and Adaptive Immune System and prospective observational studies SUGGEST that Vitamin D supplements in infancy and early childhood MAY decrease the incidence of chronic diseases such as type 1 diabetes mellitus [1,2].']	[('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 180)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007631', 'feeding behavior', 42, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 53, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 62, 'immune system'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]	0	['moreover,  modulator innate adaptive   supplements infancy childhood decrease chronic diseases type diabetes mellitus [1,2].']
S19-PMC3691177	PMC3691177	6/2013	S19-PMC3691177	['the active Metabolite of Vitamin D, 1,25-Dihydroxyvitamin D, HAS BEEN SHOWN in Animal and in vitro MODELS to have potent Immune EFFECTS[12]and a ROLE in early Lung Development[13].']	[('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_39382', 'flufenoxuron', 11, 'metabolite'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 36, '1,25-dihydroxyvitamin D'), ('NCBITaxon_33208', 'Metazoa', 79, 'animal'), ('UBERON_0002405', 'immune system', 121, 'immune'), ('GO_0030324', 'lung development', 159, 'lung development'), ('UBERON_0002048', 'lung', 159, 'lung')]	0	['metabolite 1,25-dihydroxyvitamin d, animal potent  effects[12]and lung development[13].']
S56-PMC3695234	PMC3695234	7/2013	S56-PMC3695234	['for example, Vitamin D IMPACTS the Innate Immune System by stimulating the Production Of Cathelicidin, which is an anti-Microbial peptide activated through toll-like receptors (tlrs).']	[('SUPERFICIAL_RELATIONSHIP', 23)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007449', 'proximal/distal pattern formation, imaginal disc', 35, 'innate immune system'), ('UBERON_0002405', 'immune system', 42, 'immune system'), ('GO_1902430', 'negative regulation of amyloid-beta formation', 75, 'production of cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'microbial')]	0	['example,  innate  production cathelicidin, anti-microbial peptide activated toll-like receptors (tlrs).']
S64-PMC3695234	PMC3695234	7/2013	S64-PMC3695234	['chi et al.16ASSESSED the INFLUENCE of Prenatal Vitamin D status on Immune function at Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune'), ('GO_0007567', 'parturition', 86, 'birth')]	0	['chi et al.16assessed prenatal  status  birth.']
S75-PMC3695234	PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]	0	['based  receptors  cells,  plays asthma atopy.19,20using single nucleotide polymorphism selection genotyping, poon et al.20found six variants asthma four atopy.']
S10-PMC3702245	PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]	0	['hydroxylation takes place kidney, converts 25(oh)d biologically metabolite, 1,25-dihydroxyvitamin d, physiologic increase calcium phosphorus absorption gut maintain calcium homeostasis mineralization osteoid bone.9\nalthough renal 1-alpha hydroxylase (cytochrome p450 [cyp]27b1) enzyme synthesis 1,25-dihydroxyvitamin d, cyp27b1 expressed nonrenal tissues produce 1,25 dihydroxyvitamin d.6,19in addition,  receptors expressed organs, tissues, cells (seefigure 1).20the 1,25-dihydroxyvitamin locally extrarenal tissues, immune cells, pancreatic beta cells, intestine, prostate, breast, organs, -responsive genes, plays physiologic cardiovascular health,21,22the adaptive innate  responses,23,24insulin secretion,25,26regulation cell proliferation, differentiation, apoptosis, inhibition angiogenesis.27\n\nvitamin homeostasis functions pregnancy\nthe  maintain calcium homeostasis.']
S47-PMC3702245	PMC3702245	6/2013	S47-PMC3702245	['RECENT STUDIES have INDICATED a ROLE for Vitamin D in the Innate Immune Response.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0045087', 'innate immune response', 58, 'innate immune response'), ('UBERON_0002405', 'immune system', 65, 'immune')]	0	['recent  innate  response.']
S52-PMC3702245	PMC3702245	6/2013	S52-PMC3702245	['IMPACT on neonate and infant\nboth in vitro and observational studies have DEMONSTRATED that Vitamin D status during Pregnancy IMPACTS the Immune Response of the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0006955', 'immune response', 138, 'immune response'), ('UBERON_0002405', 'immune system', 138, 'immune')]	0	['impact neonate infant\nboth  status pregnancy  response offspring.']
S20-PMC3717170	PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]	0	['1,25(oh)2d3suppression il-17 transcriptional blocking nuclear activated cells (nfat, cell receptor–mediated transcriptional il-17), recruitment histone deacetylase il-17 promoter, sequestration runt-related transcription (runx1) vdr.31,25(oh)2d3was induction foxp3, transcription nfat runx1 transcriptional repression.3these results mechanisms regard   autoimmune diseases.']
S32-PMC3717170	PMC3717170	5/2013	S32-PMC3717170	['with permission from christakos.60\n\nVitamin D in Immune function and disease PREVENTION\nmartin hewison (the david geffen school of medicine, university of california) detailed one of the most prominent of the SO-called nonclassical EFFECTS of Vitamin D: its ability to act as a potent modulator of Human Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 209), ('SUPERFICIAL_RELATIONSHIP', 232)]	3	[('CHEBI_28384', 'vitamin K', 36, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 36, 'Vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 298, 'human'), ('GO_0006955', 'immune response', 304, 'immune responses'), ('UBERON_0002405', 'immune system', 304, 'immune')]	0	['permission christakos.60\n\nvitamin  disease prevention\nmartin hewison (the david geffen school medicine, university california) nonclassical : ability potent modulator human  responses.']
S41-PMC3717170	PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]	0	['thus,  generalized antibacterial responses play infectious diseases.5an hewison  response  primates,  evolution primate immunity, vivo activity.']
S42-PMC3717170	PMC3717170	5/2013	S42-PMC3717170	['the Immunomodulatory EFFECTS of Vitamin D also involve the adaptive Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 21)]	1	[('GO_0007566', 'embryo implantation', 4, 'immunomodulatory'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0002405', 'immune system', 68, 'immune system')]	0	['immunomodulatory  adaptive .']
S44-PMC3717170	PMC3717170	5/2013	S44-PMC3717170	['as with antibacterial Responses to infection, it HAS BEEN PROPOSED that Adaptive Immune Responses MAY BE compromised in patients with low Serum concentrations of 25(Oh)D3, and ASSOCIATION studies HAVE SHOWN LINKS between Autoimmune disease and Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 196), ('SUPERFICIAL_RELATIONSHIP', 207)]	6	[('GO_0060033', 'anatomical structure regression', 22, 'responses'), ('GO_0051866', 'general adaptation syndrome', 72, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 81, 'immune'), ('UBERON_0001977', 'blood serum', 138, 'serum'), ('CHEBI_62946', 'ammonium sulfate', 162, '25(OH)D3'), ('UBERON_0001442', 'skeleton of manus', 221, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D')]	0	['antibacterial responses infection, adaptive  responses patients serum concentrations 25(oh)d3, autoimmune disease  deficiency.']
S45-PMC3717170	PMC3717170	5/2013	S45-PMC3717170	['the extent to which Vitamin D deficiency is a cause of Immune disease has yet to be demonstrated and will REQUIRE new prospective clinical trials of Vitamin D supplementation.']	[('FUTURE_WORK', 106), ('IMPORTANT_CONSIDERATION', 106)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]	0	['  disease  supplementation.']
S46-PMC3717170	PMC3717170	5/2013	S46-PMC3717170	['hewison STATED that it will be IMPORTANT to define WHETHER enhanced Vitamin D–mediated immunity prevents Immune disease OR WHETHER it CAN be used as therapy for these diseases.']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 105, 'immune')]	0	['hewison –mediated immunity  disease therapy diseases.']
S47-PMC3717170	PMC3717170	5/2013	S47-PMC3717170	['moreover, IT IS POSSIBLE that SOME diseases, such as leprosy and hiv infection, MAY BE ASSOCIATED with dysregulation of the core Vitamin D intracrine Immune mechanism, and MAY THEREFORE require higher circulating levels of 25(Oh)D3To reestablish normal Immune Responses.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 176)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0002405', 'immune system', 150, 'immune'), ('CHEBI_63755', 'o-nitrophenyl group', 223, '25(OH)D3to'), ('GO_0006955', 'immune response', 253, 'immune responses'), ('UBERON_0002405', 'immune system', 253, 'immune')]	0	['moreover, diseases, leprosy hiv infection, dysregulation  intracrine  mechanism, higher circulating levels 25(oh)d3to reestablish normal  responses.']
S48-PMC3717170	PMC3717170	5/2013	S48-PMC3717170	['these and OTHER facets of Vitamin D and Immune function will be IMPORTANT research challenges for the Vitamin D community.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 64)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0002405', 'immune system', 40, 'immune'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]	0	['facets    community.']
S68-PMC3717170	PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]	0	['vitamin pregnancy lactation\nvitamin preprohormone calcium metabolism homeostasis throughout life vivid pregnancy  metabolism disengaged usual constraints.12at lifecycle 25(oh)d3linked 1,25(oh)2d3production, latter 2.5 times nonpregnant levels.12this elevation 1,25(oh)2d3likely  regulation,  status  pregnancy hypothesis.']
S74-PMC3717170	PMC3717170	5/2013	S74-PMC3717170	['ADDITIONAL RESEARCH that addresses the IMPACT of Vitamin D on Immune Homeostasis during Pregnancy and its EFFECTS during early infancy and later childhood becomes ESSENTIAL.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 106), ('IMPORTANT_CONSIDERATION', 163)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0055090', 'acylglycerol homeostasis', 62, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 88, 'pregnancy')]	0	['additional   homeostasis pregnancy infancy childhood becomes essential.']
S129-PMC3717170	PMC3717170	5/2013	S129-PMC3717170	['li and colleagues have isolated Monocytes from patients and examined Expression of a number OF Genes RELATED to Vitamin D Metabolism and Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 92), ('SUPERFICIAL_RELATIONSHIP', 101)]	2	[('CL_0000576', 'monocyte', 32, 'monocytes'), ('GO_0010467', 'gene expression', 69, 'expression'), ('SO_0000704', 'gene', 95, 'genes'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 112, 'vitamin D metabolism'), ('GO_0006955', 'immune response', 137, 'immune responses'), ('UBERON_0002405', 'immune system', 137, 'immune')]	0	['li colleagues monocytes patients expression genes  metabolism  responses.']
S179-PMC3717170	PMC3717170	5/2013	S179-PMC3717170	['Vitamin D AFFECTS several pathways RELATED to inflammation and Cell Proliferation, including inhibition of aromatase (conversion from Testosterone to Estrogens), Cox2, prostaglandin receptor, Nf-κb, Hif-1 and Vegf, and stimulation of Igfbp-3 and E-Cadherin.52in addition, poor Vitamin D status is a RISK factor for several Autoimmune diseases, CONFIRMING the ROLE of this Vitamin in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBABLE_UNDERSTANDING', 344), ('SUPERFICIAL_RELATIONSHIP', 359)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 63, 'cell proliferation'), ('CHEBI_17347', 'testosterone', 134, 'testosterone'), ('CHEBI_50114', 'estrogen', 150, 'estrogens'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 162, 'COX2'), ('GO_0005883', 'neurofilament', 192, 'NF'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 199, 'HIF-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 209, 'VEGF'), ('PR_000008940', 'intraflagellar transport protein 88', 234, 'IGFBP-3'), ('PR_000001447', 'cadherin-1', 246, 'E-cadherin'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 323, 'autoimmune'), ('CHEBI_33229', 'vitamin (role)', 372, 'vitamin'), ('UBERON_0002405', 'immune system', 383, 'immune')]	0	['vitamin inflammation cell proliferation, inhibition aromatase (conversion testosterone estrogens), cox2, prostaglandin receptor, nf-κb, hif-1 vegf, stimulation igfbp-3 e-cadherin.52in addition,  status autoimmune diseases, vitamin  function.']
S164-PMC3728489	PMC3728489	7/2013	S164-PMC3728489	['fat-soluble Vitamins A and D play IMPORTANT ROLES in both Cell-Mediated and humoral Immune Responses (wintergerst et al.,2007).']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 27, 'D'), ('GO_0000911', 'cytokinesis by cell plate formation', 58, 'cell-mediated ... immune responses'), ('UBERON_0002405', 'immune system', 84, 'immune')]	0	['fat-soluble  play cell-mediated humoral  responses (wintergerst et al.,2007).']
S169-PMC3728489	PMC3728489	7/2013	S169-PMC3728489	['it HAS also BEEN SUGGESTED that maternal Intake of Vitamin E and polyunsaturated Fatty Acids during Pregnancy MAY INFLUENCE Development Of the Immune System and be IMPLICATED in childhood asthma and allergy.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 164)]	5	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin E'), ('CHEBI_35366', 'fatty acid', 81, 'fatty acids'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy'), ('GO_0002020', 'protease binding', 124, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 143, 'immune system')]	0	['maternal intake  polyunsaturated fatty acids pregnancy  childhood asthma allergy.']
S311-PMC3728489	PMC3728489	7/2013	S311-PMC3728489	['Vitamin D\nwe have DESCRIBED earlier HOW Vitamin D is PIVOTAL in early Immune Development and it is also known to be CRUCIAL for early Skeletal Development.']	[('INCOMPLETE_EVIDENCE', 18), ('EXPLICIT_QUESTION', 36), ('IMPORTANT_CONSIDERATION', 53), ('IMPORTANT_CONSIDERATION', 116)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0001822', 'kidney development', 70, 'immune development'), ('UBERON_0002405', 'immune system', 70, 'immune'), ('GO_0001501', 'skeletal system development', 134, 'skeletal development'), ('UBERON_0004288', 'skeleton', 134, 'skeletal')]	0	['vitamin d\nwe   skeletal development.']
S339-PMC3728489	PMC3728489	7/2013	S339-PMC3728489	['in particular, maternal Micronutrient deficiencies in zinc, fat-soluble vitamins (e.g., Vitamins A, D, e) and nutritional factors RELATED to Single Carbon Metabolism (e.g., Choline, Vitamins B2, B6, B12 and Folate) HAVE BEEN SHOWN to play a ROLE in cell-mediated and Humoral Immune Responses.']	[('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 241)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 24, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 88, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 97, 'A'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('GO_0046505', 'sulfolipid metabolic process', 141, 'single carbon metabolism'), ('CHEBI_15354', 'choline', 173, 'choline'), ('CHEBI_33277', 'gamma-tocotrienol', 182, 'vitamins'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 182, 'vitamins B2'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 195, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 199, 'B12'), ('CHEBI_30863', '5-azaorotic acid', 207, 'folate'), ('GO_0002544', 'chronic inflammatory response', 267, 'humoral immune responses'), ('UBERON_0002405', 'immune system', 275, 'immune')]	0	['particular, maternal micronutrient zinc, fat-soluble vitamins (e.g., d, e) nutritional single carbon metabolism (e.g., choline, vitamins b2, b6, b12 folate) play cell-mediated humoral  responses.']
S30-PMC3760821	PMC3760821	9/2013	S30-PMC3760821	['it HAS BEEN SPECULATED that SOME adverse Perinatal outcomes MAY BE due to the immunomodulatory properties of Vitamin D, which MAY assist in the appropriate Immune response to the Placenta[7].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 126)]	5	[('GO_0036268', 'swimming', 41, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 41, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('UBERON_0001987', 'placenta', 179, 'placenta')]	0	['perinatal outcomes immunomodulatory properties  response placenta[7].']
S19-PMC3773018	PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]	0	['however, regarding combined prenatal postnatal  status fs, periods  (19,20), unclear.']
S71-PMC3773018	PMC3773018	4/2013	S71-PMC3773018	['insufficient Vitamin D status is UNDESIRABLE from many viewpoints, ESPECIALLY BECAUSE of its IMPACT on bone health and Immune function.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 78), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]	0	['insufficient  status viewpoints, bone  function.']
S99-PMC3773018	PMC3773018	4/2013	S99-PMC3773018	['the biological mechanisms UNDERPINNING the ASSOCIATIONS between persistently low Vitamin D and the development of fs and then Food allergy include excessive exposure to abundant Food Allergens caused by increased Gastrointestinal Barrier permeability and decreased Immune tolerance.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 43)]	2	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_33290', 'food', 126, 'food'), ('CHEBI_33290', 'food', 178, 'food'), ('CHEBI_33663', 'cyclic hydrocarbon', 183, 'allergens'), ('UBERON_0010172', 'bulb of aorta', 213, 'gastrointestinal barrier'), ('UBERON_0002405', 'immune system', 265, 'immune')]	0	['biological mechanisms  fs food allergy excessive exposure abundant food allergens gastrointestinal permeability decreased  tolerance.']
S102-PMC3798907	PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]	0	['embarking  pregnancy  supplementation neonatal  responses,  supplementation, dietary increase  intake.']
S151-PMC3798907	PMC3798907	8/2013	S151-PMC3798907	['conclusions\noverall, THIS WORK DEMONSTRATES that in vitro supplementation of cbmc with Vitamins E or C CAN INFLUENCE their Immune function but NOT in the simple and consistent manner predicted by models arising from observational epidemiological studies.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 107), ('ANOMALY_CURIOUS_FINDING', 143)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 101, 'C'), ('UBERON_0002405', 'immune system', 123, 'immune')]	0	['conclusions\noverall, supplementation cbmc  c  manner arising epidemiological studies.']
S10-PMC3814422	PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]	0	['introduction\nvitamin play normal fetal lung  development1and maternal  status pregnancy causally asthma atopy offspring.']
S63-PMC3827489	PMC3827489	10/2013	S63-PMC3827489	['Vitamin D insufficiency/deficiency and Respiratory diseases\nemerging EVIDENCE SUGGESTS that Vitamin D plays an ESSENTIAL ROLE in the Modulation Of the Immune Responses.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001004', 'respiratory system', 39, 'respiratory'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0006880', 'intracellular sequestering of iron ion', 133, 'modulation of ... immune responses'), ('UBERON_0002405', 'immune system', 151, 'immune')]	0	['vitamin insufficiency/deficiency respiratory diseases\nemerging  plays  responses.']
S64-PMC3827489	PMC3827489	10/2013	S64-PMC3827489	['in addition, Vitamin D HAS BEEN recognized as an anti-infective agent due TO its EFFECTS on Innate and Adaptive Immune Responses.']	[('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007631', 'feeding behavior', 92, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 103, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 112, 'immune')]	0	['addition,  anti-infective agent innate adaptive  responses.']
S1-PMC4045304	PMC4045304	2/2014	S1-PMC4045304	['though both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.']	[('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 119), ('SUPERFICIAL_RELATIONSHIP', 174), ('SUPERFICIAL_RELATIONSHIP', 182), ('INCOMPLETE_EVIDENCE', 254)]	7	[('SO_0000704', 'gene', 12, 'genetic'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_30751', 'formic acid', 214, 'folic acid'), ('GO_0008152', 'metabolic process', 230, 'metabolic')]	0	['though genetic environmental extensively, nutritional  folic acid, metabolic syndrome received attention.']
S1-PMC4072587	PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]	0	['bone homeostasis, brain  antenatal  infant outcomes understood.']
S39-PMC4106226	PMC4106226	7/2014	S39-PMC4106226	['RECENT STUDIES SUGGEST that Vitamin D deficiency MAY increase the RISK of developing Autoimmune diseases including type 1 diabetes (t1dm), by Modulating the Immune and inflammatory reactions.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 49), ('IMPORTANT_CONSIDERATION', 66)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 85, 'autoimmune'), ('GO_0065007', 'biological regulation', 142, 'modulating'), ('UBERON_0002405', 'immune system', 157, 'immune')]	0	['recent  increase autoimmune diseases type diabetes (t1dm),  inflammatory reactions.']
S253-PMC4113768	PMC4113768	7/2014	S253-PMC4113768	['hiv progression, which is ASSOCIATED with excessive Immune Activation and impaired T-Cell Immunity, is also ASSOCIATED with low Serum Vitamin D level ALTHOUGH biological PLAUSIBILITY and causality have yet to be established.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('ANOMALY_CURIOUS_FINDING', 150), ('INCOMPLETE_EVIDENCE', 170)]	5	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 52, 'immune activation'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CL_0000084', 'T cell', 83, 'T-cell'), ('GO_0002456', 'T cell mediated immunity', 83, 'T-cell immunity'), ('GO_0005622', 'intracellular anatomical structure', 84, '-cell'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]	0	['hiv progression, excessive  activation t-cell immunity, serum  biological causality established.']
S1540-PMC4113768	PMC4113768	7/2014	S1540-PMC4113768	['background: Vitamin D IS KNOWN to AFFECT Immune function; HOWEVER it is UNCERTAIN IF Vitamin D CAN alter the Immune Response towards the persistent herpesviruses, Ebv and Cmv.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('FULL_UNKNOWN', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 95)]	6	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0006955', 'immune response', 109, 'immune response'), ('UBERON_0002405', 'immune system', 109, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'EBV'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'CMV')]	0	['background: vitamin  function;  alter  response herpesviruses, ebv cmv.']
S1576-PMC4113768	PMC4113768	7/2014	S1576-PMC4113768	['Vitamin D MAY aid in supporting the Innate and Adaptive Immune Responses, and henceforth Cd4 T-Cell preservation; STUDIES have FOUND that Vitamin D insufficiency was ASSOCIATED with cd4 changes after Antiretroviral Therapy (art) initiation (aziz, m., et al .']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 166)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007631', 'feeding behavior', 36, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 47, 'adaptive immune responses'), ('UBERON_0002405', 'immune system', 56, 'immune'), ('CL_0000810', 'CD4-positive, alpha-beta thymocyte', 89, 'CD4 T-cell'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 200, 'antiretroviral'), ('GO_0003064', 'regulation of heart rate by hormone', 200, 'antiretroviral therapy')]	0	['vitamin innate adaptive  responses, henceforth cd4 t-cell preservation;  cd4 changes antiretroviral therapy (art) initiation (aziz, m., et al .']
S2051-PMC4113768	PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]	0	['evaluation vitamin status immune response children respiratory tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: addition skeletal effects,  plays  response.']
S2066-PMC4113768	PMC4113768	7/2014	S2066-PMC4113768	['conclusions: the results of THIS STUDY SUGGEST an IMPORTANT ROLE for Vitamin D in the modulation of Immune response in children with Lower Respiratory Tract infections.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 60)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('UBERON_0004905', 'articulation', 133, 'lower respiratory tract')]	0	['conclusions: results   response children respiratory tract infections.']
S2781-PMC4113768	PMC4113768	7/2014	S2781-PMC4113768	['EVIDENCE from other Tissues INDICATES that local Synthesis Of active Vitamin D (1,25-Dihydroxy Vitamin D; 1,25(Oh)2D3) INFLUENCES Immune Responses and in particular Tlr Signalling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('UBERON_0000479', 'tissue', 20, 'tissues'), ('GO_0051610', 'serotonin uptake', 49, 'synthesis of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 80, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 107, ',25(OH)2D3'), ('GO_0006955', 'immune response', 130, 'immune responses'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0031929', 'TOR signaling', 165, 'TLR signalling')]	0	['evidence tissues local synthesis  (1,25-dihydroxy 1,25(oh)2d3)  responses tlr signalling.']
S214-PMC4161853	PMC4161853	8/2014	S214-PMC4161853	['HENCE, Vitamin A plays an IMPORTANT ROLE in the Intestinal Immune System as a source of Retinoic Acid (Ra), a Gut-homing factor for Iga Secreting cells in Intestinal Mucosa [117,118].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin A'), ('UBERON_0000160', 'intestine', 48, 'intestinal'), ('GO_0007566', 'embryo implantation', 59, 'immune'), ('UBERON_0002405', 'immune system', 59, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid'), ('CHEBI_36927', 'carbon-14 atom', 103, 'RA'), ('UBERON_0001555', 'digestive tract', 110, 'gut'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 132, 'IgA'), ('GO_0046903', 'secretion', 136, 'secreting'), ('UBERON_0001242', 'intestinal mucosa', 155, 'intestinal mucosa'), ('CL_0000187', 'muscle cell', 166, 'mucosa')]	0	['hence,  plays intestinal  retinoic acid (ra), gut-homing iga secreting cells intestinal mucosa [117,118].']
S217-PMC4161853	PMC4161853	8/2014	S217-PMC4161853	['moreover, Gestational Vitamin A deficiency in Animal models HAS BEEN SHOWN to reduce the Intestinal Immune Response by decreasing the number of Immune Cells in Rat offspring [119] and Controlling the size of Secondary Lymph Organ and the efficiency of Immune Responses in the Adult Mouse offspring [120].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 46, 'animal'), ('UBERON_0000160', 'intestine', 89, 'intestinal'), ('GO_0006955', 'immune response', 100, 'immune response'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('CL_0000738', 'leukocyte', 144, 'immune cells'), ('UBERON_0002405', 'immune system', 144, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rat'), ('GO_0065007', 'biological regulation', 184, 'controlling'), ('UBERON_0005174', 'dorsal region element', 208, 'secondary lymph organ'), ('GO_0006955', 'immune response', 252, 'immune responses'), ('UBERON_0002405', 'immune system', 252, 'immune'), ('UBERON_0007023', 'adult organism', 276, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'mouse')]	0	['moreover, gestational  animal intestinal  response decreasing  cells rat offspring [119] controlling secondary lymph organ efficiency  responses adult mouse offspring [120].']
S231-PMC4161944	PMC4161944	9/2014	S231-PMC4161944	['independent of nutrition or pathogen exposure, seasonality CAN also change diurnal exposure to sunlight and levels of circulating Vitamin D. in the united kingdom, Vitamin D status during Gestation and Birth month HAS BEEN ASSOCIATED with diseases with Immune involvement, including rheumatoid arthritis, irritable Bowel diseases, and multiple sclerosis (174).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 223)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0002405', 'immune system', 253, 'immune'), ('UBERON_0000160', 'intestine', 315, 'bowel')]	0	['independent nutrition pathogen exposure, seasonality diurnal exposure sunlight levels circulating . united kingdom,  status gestation birth month diseases  involvement, rheumatoid arthritis, irritable bowel diseases, sclerosis (174).']
S2-PMC4251419	PMC4251419	12/2014	S2-PMC4251419	['there are PLAUSIBLE pathways whereby Vitamin D deficiency CAN impair Immune function, resulting in both overactivity and increased risk of Autoimmune disease, as well as Immune suppression with poorer resistance to infection.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 58)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('UBERON_0001442', 'skeleton of manus', 139, 'autoimmune'), ('UBERON_0002405', 'immune system', 170, 'immune')]	0	['whereby   function, resulting overactivity autoimmune disease,  suppression resistance infection.']
S7-PMC4251419	PMC4251419	12/2014	S7-PMC4251419	['after the UNDISPUTED IMPORTANCE of Vitamin D for bone health, the STRONGEST EVIDENCE is PROBABLY for an increased RISK of Immune disorders in ASSOCIATION with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 10), ('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 88), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]	0	[' bone health,  disorders  deficiency.']
S9-PMC4251419	PMC4251419	12/2014	S9-PMC4251419	['clues from epidemiology\nindications that Vitamin D MAY BE ASSOCIATED with disorders of Human Immune function OFTEN originate from OBSERVATIONS of geographic VARIATION in disease occurrence.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 109), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 157)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 87, 'human'), ('UBERON_0002405', 'immune system', 93, 'immune')]	0	['clues epidemiology\nindications  disorders human  originate geographic disease occurrence.']
S15-PMC4251419	PMC4251419	12/2014	S15-PMC4251419	['both uvr and Vitamin D (in its active form 1,25(Oh)2D, seefigure 1) have immunomodulatory EFFECTS [8] that provide a PLAUSIBLE mechanism whereby higher levels COULD decrease the risk of Autoimmune diseases (see section on mechanisms, below) and, through the same pathways, COULD impair the Immune Response to vaccination or infection [9,10].']	[('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 273)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_17996', 'chloride', 44, ','), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 45, '25(OH)2D'), ('UBERON_0001442', 'skeleton of manus', 186, 'autoimmune'), ('GO_0006955', 'immune response', 290, 'immune response'), ('UBERON_0002405', 'immune system', 290, 'immune')]	0	['uvr  (in form 1,25(oh)2d, seefigure 1) immunomodulatory [8] whereby higher levels decrease autoimmune diseases (see section mechanisms, below) and, pathways,  response vaccination infection [9,10].']
S23-PMC4251419	PMC4251419	12/2014	S23-PMC4251419	['HOWEVER, for AT LEAST some of the Immune-RELATED diseases, it is DIFFICULT to determine WHETHER low sun exposure OR Vitamin D cause, OR are caused by, the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	5	[('UBERON_0002405', 'immune system', 34, 'immune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]	0	['however, -related diseases, sun exposure  cause, by, disease.']
S27-PMC4251419	PMC4251419	12/2014	S27-PMC4251419	['DESPITE these relatively COHERENT FINDINGS from ecologic and OBSERVATIONAL studies, and PLAUSIBLE biological mechanisms, trials of Vitamin D supplementation for the PREVENTION of Immune-related diseases have LARGELY returned null results [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 208)]	8	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0002405', 'immune system', 179, 'immune')]	0	['despite ecologic studies, biological mechanisms,  supplementation -related diseases returned results [17].']
S30-PMC4251419	PMC4251419	12/2014	S30-PMC4251419	['NEVERTHELESS, there is not yet COMPELLING EVIDENCE from these studies that Vitamin D supplementation ameliorates any Immune-related disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('UBERON_0002405', 'immune system', 117, 'immune')]	0	['nevertheless,  supplementation ameliorates -related disease.']
S32-PMC4251419	PMC4251419	12/2014	S32-PMC4251419	['this BELIEF is DRIVEN BY recognition of cellular Expression of the Vitamin D receptor (vdr), the FINDING of multiple primary 1,25(Oh)2D target Genes in Immune Cells and the discovery that many Immune Cells (Macrophages, Dendritic Cells, T and B Lymphocytes) CAN convert 25(Oh)D to 1,25(Oh)2D through Cyp27B1 activity and therefore provide significant local levels of 1,25(Oh)2D for functional outcomes (for review [8,19]).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 258)]	4	[('GO_0010467', 'gene expression', 49, 'expression'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 125, '1,25(OH)2D'), ('SO_0000704', 'gene', 143, 'genes'), ('CL_0000738', 'leukocyte', 152, 'immune cells'), ('UBERON_0002405', 'immune system', 152, 'immune'), ('CL_0000738', 'leukocyte', 193, 'immune cells'), ('UBERON_0002405', 'immune system', 193, 'immune'), ('CL_0000235', 'macrophage', 207, 'macrophages'), ('CL_0000451', 'dendritic cell', 220, 'dendritic cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 237, 'T ...'), ('CL_0000236', 'B cell', 243, 'B lymphocytes'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('CHEBI_82784', 'PVP38-Ag NP', 281, '1,25(OH)2D'), ('PR_000006101', 'cytochrome P450 1A1', 300, 'CYP27B1'), ('CHEBI_82784', 'PVP38-Ag NP', 367, '1,25(OH)2D')]	0	['cellular expression  receptor (vdr), 1,25(oh)2d genes  cells  cells (macrophages, dendritic cells, b lymphocytes) convert 25(oh)d 1,25(oh)2d cyp27b1 activity local levels 1,25(oh)2d functional outcomes (for [8,19]).']
S33-PMC4251419	PMC4251419	12/2014	S33-PMC4251419	['the amount of 1,25(Oh)2D produced MAY depend on the ability of Immune Cells to Express Cyp27B1 and OTHER enzymatic machinery of the Vitamin D pathway, including the Cyp24A1 deactivation enzyme.']	[('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	2	[('CHEBI_37958', 'dye', 14, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 16, '25(OH)2D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('GO_0010467', 'gene expression', 79, 'express'), ('PR_000006101', 'cytochrome P450 1A1', 87, 'CYP27B1'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 165, 'CYP24A1')]	0	['amount 1,25(oh)2d ability  cells express cyp27b1 enzymatic machinery  pathway, cyp24a1 deactivation enzyme.']
S68-PMC4251419	PMC4251419	12/2014	S68-PMC4251419	['multiple sclerosis: a case study\none of the earliest INDICATIONS of an ASSOCIATION between Vitamin D and disorders of Human Immune function was the geographical variation in prevalence of multiple sclerosis, as first described in 1922 [36].']	[('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0002405', 'immune system', 124, 'immune')]	0	['multiple sclerosis: study\none  disorders human  geographical sclerosis, 1922 [36].']
S87-PMC4251419	PMC4251419	12/2014	S87-PMC4251419	['an indirect pathway: Vitamin D, Immunity and the microbiome\nfollowing interactions with pathogens, Immune Cells like Monocytes can synthesise 1,25(Oh)2D, POSSIBLY through activation of specialised Immune receptors like the toll-like receptors [54], or following stimulation with other Immune-modulators like Tgfβ or interferon-γ [55].']	[('INCOMPLETE_EVIDENCE', 154)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007566', 'embryo implantation', 32, 'immunity'), ('CL_0000738', 'leukocyte', 99, 'immune cells'), ('UBERON_0002405', 'immune system', 99, 'immune'), ('CL_0000576', 'monocyte', 117, 'monocytes'), ('CHEBI_82784', 'PVP38-Ag NP', 142, '1,25(OH)2D'), ('UBERON_0002405', 'immune system', 197, 'immune'), ('UBERON_0002405', 'immune system', 285, 'immune'), ('PR_000000046', 'TGF-beta', 308, 'TGFβ')]	0	['pathway: immunity microbiome\nfollowing pathogens,  cells monocytes synthesise 1,25(oh)2d, activation specialised  receptors toll-like receptors [54], following stimulation -modulators tgfβ interferon-γ [55].']
S98-PMC4251419	PMC4251419	12/2014	S98-PMC4251419	['a PROPOSED network of INTERACTIONS between Vitamin D and the microbiome that MAY sway the Development Of Immune Tolerance or Tissue Inflammation\nActivation Of Immune Cells like Monocytes and Epithelial cells by bacterial-derived products (e.g.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0032253', 'dense core granule localization', 90, 'development of ... tolerance ... inflammation'), ('UBERON_0002405', 'immune system', 105, 'immune'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('GO_0006915', 'apoptotic process', 145, 'Activation of immune cells'), ('CL_0000738', 'leukocyte', 159, 'immune cells'), ('UBERON_0002405', 'immune system', 159, 'immune'), ('CL_0000576', 'monocyte', 177, 'monocytes'), ('CL_0000066', 'epithelial cell', 191, 'epithelial'), ('UBERON_0000483', 'epithelium', 191, 'epithelial')]	0	[' microbiome sway  tolerance tissue inflammation\nactivation  cells monocytes epithelial cells bacterial-derived products (e.g.']
S101-PMC4251419	PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]	0	['alternatively, microbiome changes, induced following probiotics, regulate responsiveness  cells  expression  receptor (vdr) reducing tissue inflammation.']
S110-PMC4251419	PMC4251419	12/2014	S110-PMC4251419	['collectively, these studies SUGGEST that Vitamin D is instrumental in Regulating the microbiome of the Lungs and Gut, and is ENTWINED with the maintenance of Immune tolerance.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0065007', 'biological regulation', 70, 'regulating'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0001555', 'digestive tract', 113, 'gut'), ('UBERON_0002405', 'immune system', 158, 'immune')]	0	['collectively,  microbiome lungs gut, maintenance  tolerance.']
S111-PMC4251419	PMC4251419	12/2014	S111-PMC4251419	['as Murine STUDIES are STARTING TO illustrate in the Gut and Lungs, the interplay between Vitamin D, the microbiome and Immune tolerance MAY also curb skin inflammation.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 136)]	4	[('NCBITaxon_39107', 'Murinae', 3, 'murine'), ('UBERON_0001555', 'digestive tract', 52, 'gut'), ('UBERON_0002048', 'lung', 60, 'lungs'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]	0	['gut lungs, microbiome  tolerance skin inflammation.']
S137-PMC4251419	PMC4251419	12/2014	S137-PMC4251419	['HOWEVER, SEVERAL STUDIES SUGGEST that low Vitamin D status or low levels of ambient uvr during the in utero period [49], or during childhood [40], are ASSOCIATED with increased risk of Immune-related disorders.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002405', 'immune system', 185, 'immune')]	0	['however,  status levels ambient uvr utero period [49], childhood [40], -related disorders.']
S160-PMC4251419	PMC4251419	12/2014	S160-PMC4251419	['conclusion\nthe jury is STILL out on the IMPORTANCE of Vitamin D for Immune function: both for Vitamin D deficiency increasing the RISK of Autoimmune diseases and Viral infections through loss of Regulatory Adaptive Immune functions, as well as for high Vitamin D levels decreasing the risks of tuberculosis and infections with other Intracellular pathogens through upregulation of Innate Immunity.']	[('IMPORTANT_CONSIDERATION', 23), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 130)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 138, 'autoimmune'), ('NCBITaxon_1', 'root', 162, 'viral'), ('GO_0008016', 'regulation of heart contraction', 195, 'regulatory adaptive immune'), ('UBERON_0002405', 'immune system', 215, 'immune'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('GO_0005622', 'intracellular anatomical structure', 333, 'intracellular'), ('GO_0045087', 'innate immune response', 381, 'innate immunity')]	0	['conclusion\nthe jury   function:  autoimmune diseases viral infections loss adaptive  functions,  levels decreasing tuberculosis infections intracellular pathogens upregulation innate immunity.']
S1-PMC4263713	PMC4263713	12/2014	S1-PMC4263713	['our PREVIOUS STUDY DEMONSTRATED that Gestational or early-Life Vitamin A deficiency decreases the number of Immune Cells in offspring.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 19)]	2	[('GO_0007565', 'female pregnancy', 37, 'gestational'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('CL_0000738', 'leukocyte', 108, 'immune cells'), ('UBERON_0002405', 'immune system', 108, 'immune')]	0	['gestational early-life  decreases  cells offspring.']
S27-PMC4302429	PMC4302429	1/2015	S27-PMC4302429	['cells of the Immune System possess Vitamin D receptors and are capable of Metabolizing the active form of Vitamin D (1,25(Oh)2D3) [15], SUGGESTING Vitamin D as an IMPORTANT FACTOR in the Immune Response to Infection [16].']	[('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 163), ('SUPERFICIAL_RELATIONSHIP', 173)]	3	[('UBERON_0002405', 'immune system', 13, 'immune system'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0008152', 'metabolic process', 74, 'metabolizing'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 117, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0006955', 'immune response', 187, 'immune response'), ('UBERON_0002405', 'immune system', 187, 'immune'), ('GO_0007586', 'digestion', 206, 'infection')]	0	['cells  possess  receptors capable metabolizing form  (1,25(oh)2d3) [15],   response infection [16].']
S28-PMC4302429	PMC4302429	1/2015	S28-PMC4302429	['studies of the Innate Immune Response to pathogens such as mycobacterium tuberculosis HAVE SHOWN that pathogen-recognition receptor (prr)-mediated activation of localized Vitamin D Metabolism and signaling is a key event ASSOCIATED with resistance to infection [17].']	[('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 221)]	2	[('GO_0045087', 'innate immune response', 15, 'innate immune response'), ('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 171, 'vitamin D metabolism')]	0	['studies innate  response pathogens mycobacterium tuberculosis pathogen-recognition receptor (prr)-mediated activation localized  metabolism signaling event resistance infection [17].']
S125-PMC4302429	PMC4302429	1/2015	S125-PMC4302429	['high Vitamin D3 concentrations inhibited the Production of proinflammatory cytokine Il-6 and increased production of anti-inflammatory cytokine Il-10, WHILE Ifn-Γ production in the Cns stayed unaffected\nPREVIOUS investigations REVEALED that Vitamin D plays IMPORTANT ROLES in signaling in both the Adaptive and Innate Immune Response To Viral and bacterial Infection [16,25].']	[('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 227), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267)]	5	[('CHEBI_33279', 'vitamin D5', 5, 'vitamin D3'), ('GO_0007128', 'meiotic prophase I', 45, 'production'), ('PR_000001470', 'interleukin-28B', 84, 'IL-6'), ('PR_000001470', 'interleukin-28B', 144, 'IL-10'), ('PR_000008920', 'interferon alpha-7', 157, 'IFN-γ'), ('UBERON_0001017', 'central nervous system', 181, 'CNS'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('GO_0051886', 'negative regulation of timing of anagen', 298, 'adaptive ...'), ('GO_0045048', 'protein insertion into ER membrane', 311, 'innate immune response to ... infection'), ('UBERON_0002405', 'immune system', 318, 'immune'), ('NCBITaxon_1', 'root', 337, 'viral')]	0	['high vitamin d3 concentrations inhibited production proinflammatory cytokine il-6 production anti-inflammatory cytokine il-10, ifn-γ production cns stayed unaffected\nprevious  plays signaling adaptive innate  response viral bacterial infection [16,25].']
S161-PMC4302429	PMC4302429	1/2015	S161-PMC4302429	['clinical and experimental observations SUPPORT the HYPOTHESIS that Vitamin D has an EFFECT on the Immune Response to infection and the ability to eliminate pathogens after entry Into the host.']	[('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 84)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0006955', 'immune response', 98, 'immune response'), ('UBERON_0002405', 'immune system', 98, 'immune'), ('GO_0007631', 'feeding behavior', 178, 'into')]	0	['clinical   response infection ability eliminate pathogens host.']
S163-PMC4302429	PMC4302429	1/2015	S163-PMC4302429	['a central feature of many of these NON-CLASSICAL actions of Vitamin D is RELATED to the synthesis of active 1,25(Oh)2D in a cell-specific manner: enzyme 25Ohd-1α-hydroxylase (encoded by the Gene Cyp27B1 ) is Expressed by many Extrarenal Tissues, including the Immune System [14,34].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 108, '1,25(OH)2D'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 153, '25OHD'), ('SO_0000704', 'gene', 190, 'gene'), ('PR_000006101', 'cytochrome P450 1A1', 195, 'CYP27B1'), ('GO_0010467', 'gene expression', 208, 'expressed'), ('UBERON_0005292', 'extraembryonic tissue', 226, 'extrarenal tissues'), ('UBERON_0002405', 'immune system', 260, 'immune system')]	0	['central  synthesis 1,25(oh)2d cell-specific manner: enzyme 25ohd-1α-hydroxylase (encoded gene cyp27b1 expressed extrarenal tissues,  [14,34].']
S166-PMC4302429	PMC4302429	1/2015	S166-PMC4302429	['TO ASSESS the ROLE of Vitamin D in an in-vivo experimental MODEL of bacterial Cns infection, we analyzed the INFLUENCE of the infection on the survival and Immune Response of Mice Fed a diet containing different amounts of Vitamin D3 after injection of E. Coli directly into the right Frontal Lobe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 78, 'CNS'), ('GO_0006955', 'immune response', 156, 'immune response'), ('UBERON_0002405', 'immune system', 156, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'mice'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('CHEBI_33279', 'vitamin D5', 223, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 223, 'vitamin D3'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'E. coli'), ('UBERON_0016525', 'frontal lobe', 285, 'frontal lobe')]	0	[' in-vivo bacterial cns infection, infection survival  response mice fed diet containing amounts vitamin d3 injection e. coli frontal lobe.']
S186-PMC4302429	PMC4302429	1/2015	S186-PMC4302429	['PRESUMABLY, in addition to Cathelicidin, OTHER Immune Mediators are INVOLVED in the Vitamin D-dependent Immune pathways.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_3364', 'Canthiumine', 27, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 27, 'cathelicidin'), ('UBERON_0002405', 'immune system', 47, 'immune'), ('CHEBI_35222', 'inhibitor', 54, 'mediators'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0002405', 'immune system', 104, 'immune')]	0	['presumably, addition cathelicidin,  -dependent  pathways.']
S190-PMC4302429	PMC4302429	1/2015	S190-PMC4302429	['a study on the Immune Response to an allergic stimulus in Mice in vivo SUGGESTED that Vitamin D supplementation (100\xa0ng 1,25(Oh)2D injection) given after the initial period of sensitization prevented high levels of Eosinophils ASSOCIATED with a reduced local inflammatory response in Bronchoalveolar Lavage Fluid and Lung Tissue.']	[('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 227)]	2	[('GO_0006955', 'immune response', 15, 'immune response'), ('UBERON_0002405', 'immune system', 15, 'immune'), ('NCBITaxon_10088', 'Mus <genus>', 58, 'mice'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 120, '1,25(OH)2D'), ('CL_0000771', 'eosinophil', 215, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 284, 'bronchoalveolar lavage fluid'), ('UBERON_0002048', 'lung', 317, 'lung tissue')]	0	[' response allergic stimulus mice vivo  supplementation (100\xa0ng 1,25(oh)2d injection) period sensitization levels eosinophils local inflammatory response bronchoalveolar lavage fluid lung tissue.']
S26-PMC4329404	PMC4329404	10/2014	S26-PMC4329404	['the ROLE of Vitamin D as an immunomodulator is BETTER DEFINED, with Vitamin D skewing the Immune System towards Regulation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 90, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation')]	0	[' immunomodulator defined,  skewing  regulation.']
S30-PMC4329404	PMC4329404	10/2014	S30-PMC4329404	['Pregnant females were Fed a Vitamin D-deficient diet starting from day-16 Gestation (last trimester) to FOCUS on Immune-mediated mechanisms of disease development in offspring and to limit any EFFECTS of in utero Vitamin D deficiency on foetal Lung growth and Development (27).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 104), ('SUPERFICIAL_RELATIONSHIP', 193)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007631', 'feeding behavior', 22, 'fed'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestation'), ('UBERON_0002405', 'immune system', 113, 'immune'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0030324', 'lung development', 244, 'lung ... development'), ('UBERON_0002048', 'lung', 244, 'lung')]	0	['pregnant females fed -deficient diet day-16 gestation (last trimester) -mediated mechanisms disease offspring utero  foetal lung (27).']
S133-PMC4329404	PMC4329404	10/2014	S133-PMC4329404	['discussion\nwe HAVE SHOWN that Adult female Mice given a Vitamin D-deficient diet for 4\xa0weeks (from day-16 Gestation until 3\xa0weeks Postpartum) developed a th2-skewed Pulmonary Immune phenotype, concomitant with reduced Cd4+Il-10+Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('UBERON_0007023', 'adult organism', 30, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('GO_0007565', 'female pregnancy', 130, 'postpartum'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('PR_000001204', 'C-C chemokine receptor type 8', 218, 'CD4'), ('PR_000001470', 'interleukin-28B', 222, 'IL-10'), ('CL_0000232', 'erythrocyte', 228, 'regulatory cells'), ('GO_0065007', 'biological regulation', 228, 'regulatory')]	0	['discussion\nwe adult female mice 4\xa0weeks (from day-16 gestation 3\xa0weeks postpartum) th2-skewed pulmonary  phenotype, cd4+il-10+regulatory cells.']
S139-PMC4329404	PMC4329404	10/2014	S139-PMC4329404	['we HAVE SHOWN EFFECTS on Immune phenotype after ONLY 4\xa0weeks of a Vitamin D-deficient diet in females.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 48)]	3	[('UBERON_0002405', 'immune system', 25, 'immune'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]	0	[' phenotype 4\xa0weeks -deficient diet females.']
S164-PMC4377870	PMC4377870	3/2015	S164-PMC4377870	['the extra-Skeletal EFFECTS of Vitamin D are WELL DOCUMENTED in both asthma and copd, and deficiency is ASSOCIATED with negative Respiratory and Immune outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('UBERON_0004288', 'skeleton', 10, 'skeletal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 128, 'respiratory'), ('UBERON_0002405', 'immune system', 144, 'immune')]	0	['extra-skeletal  asthma copd, respiratory  outcomes.']
S250-PMC4377870	PMC4377870	3/2015	S250-PMC4377870	['the EVIDENCE for mechanisms of Vitamin D in Lung Development and Immune function are yet to be fully established.']	[('INCOMPLETE_EVIDENCE', 4)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0030324', 'lung development', 44, 'lung development'), ('UBERON_0002048', 'lung', 44, 'lung'), ('GO_0007566', 'embryo implantation', 65, 'immune'), ('UBERON_0002405', 'immune system', 65, 'immune')]	0	['mechanisms  lung  established.']
S87-PMC4377879	PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]	0	['despite bone homeostasis, brain antenatal  [40], cut-off points.']
S184-PMC4417995	PMC4417995	4/2015	S184-PMC4417995	['these OBSERVATIONS are SUPPORTED by basic research data SHOWING that Vitamin D acts on many different Immune Cell functions.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 56)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CL_0000738', 'leukocyte', 102, 'immune cell'), ('UBERON_0002405', 'immune system', 102, 'immune')]	0	['  cell functions.']
S185-PMC4448820	PMC4448820	5/2015	S185-PMC4448820	['AS a result of increased INTEREST in the activities of Vitamin D beyond the traditional FOCUS on bone/calcium, an IMPORTANT NEW UNDERSTANDING of Vitamin D’s ROLE in Immune function has EMERGED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 185)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0002405', 'immune system', 165, 'immune')]	0	['result activities  bone/calcium, ’s  emerged.']
S280-PMC4448820	PMC4448820	5/2015	S280-PMC4448820	['a. mechanisms of Vitamin A EFFECT on the Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('UBERON_0002405', 'immune system', 41, 'immune system')]	0	['a. mechanisms  .']
S281-PMC4448820	PMC4448820	5/2015	S281-PMC4448820	['most of the EFFECTS of Vitamin A on Immune or inflammatory Responses CAN be EXPLAINED via binding of the Vitamin A Metabolite, Atra, to 1 of 3 zinc-finger proteins containing members of the Nuclear receptor superfamily, Rar-Α, Rar-Β, and Rar-Γ (185).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0006955', 'immune response', 36, 'immune ... responses'), ('UBERON_0002405', 'immune system', 36, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 115, 'metabolite'), ('CHEBI_17033', 'biliverdin', 127, 'ATRA'), ('GO_0005634', 'nucleus', 190, 'nuclear'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 220, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 227, 'RAR-β'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 238, 'RAR-γ')]	0	['  inflammatory responses via binding  metabolite, atra, 3 zinc-finger proteins containing members nuclear receptor superfamily, rar-α, rar-β, rar-γ (185).']
S289-PMC4448820	PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]	0	['although magnitude relations,  genetically  response via activities atra.']
S290-PMC4448820	PMC4448820	5/2015	S290-PMC4448820	['b. mechanisms of Vitamin D EFFECT on the Immune System.']	[('SUPERFICIAL_RELATIONSHIP', 27)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002405', 'immune system', 41, 'immune system')]	0	['b. mechanisms  .']
S296-PMC4448820	PMC4448820	5/2015	S296-PMC4448820	['like Vitamin A, Vitamin D CAN AFFECT Immune function through this Genetic INTERACTION.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 37, 'immune'), ('SO_0000704', 'gene', 66, 'genetic')]	0	['like   genetic interaction.']
S346-PMC4448820	PMC4448820	5/2015	S346-PMC4448820	['ROLE of Vitamin A in epigenetic processes and the genetics of Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin A'), ('UBERON_0002405', 'immune system', 62, 'immune')]	0	['role  epigenetic processes genetics  function.']
S354-PMC4448820	PMC4448820	5/2015	S354-PMC4448820	['EVIDENCE for EFFECTS of Vitamin A on epigenetic Regulation Of Immune Function is EMERGING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 81)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('GO_0002019', 'regulation of renal output by angiotensin', 48, 'regulation of immune function'), ('UBERON_0002405', 'immune system', 62, 'immune')]	0	['evidence  epigenetic  emerging.']
S372-PMC4448820	PMC4448820	5/2015	S372-PMC4448820	['ROLE of Vitamin D in epigenetic processes and the genetics of Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002405', 'immune system', 62, 'immune')]	0	['role  epigenetic processes genetics  function.']
S471-PMC4448820	PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]	0	['although  absolutely  response, temporarily inhibiting plasma delivery  tissues host creating environment inflammation.']
S473-PMC4448820	PMC4448820	5/2015	S473-PMC4448820	['caption (boxed-text): text box 17\u2003\nPOSSIBLE mechanisms to EXPLAIN Vitamin A’s ROLE in Immune Response\n\n● vitamin A, via conversion to atra, can inhibit Nf-Κb Activation (118).']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0006955', 'immune response', 86, 'immune response'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('PR_000004370', 'asialoglycoprotein receptor 2', 113, 'A'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 152, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 152, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 152, 'NF-κB')]	0	['caption (boxed-text): text box 17\u2003\npossible mechanisms ’s  response\n\n● vitamin a, via conversion atra, inhibit nf-κb activation (118).']
S525-PMC4448820	PMC4448820	5/2015	S525-PMC4448820	['caption (boxed-text): text box 19\u2003\nwg 2 summary and conclusions\n\n● the review uses data on 3 Micronutrients (Vitamin A, zinc, and iron), anthropometrically defined undernutrition (stunting, wasting, and underweight), and obesity TO EVALUATE the EFFECT on the following:\n○ Immune function,\n○ recovery of immune function in response to nutritional interventions,\n○ RELATED health outcomes (e.g., risk of infection), and\n○ MARKERS of inflammation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('SUPERFICIAL_RELATIONSHIP', 245), ('SUPERFICIAL_RELATIONSHIP', 363), ('SUPERFICIAL_RELATIONSHIP', 420)]	4	[('CHEBI_33839', 'macromolecule', 93, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('UBERON_0002405', 'immune system', 272, 'immune')]	0	['caption (boxed-text): text box 19\u2003\nwg 2 conclusions\n\n● uses 3 micronutrients (, zinc, iron), anthropometrically undernutrition (stunting, wasting, underweight), obesity following:\n○  function,\n○ recovery immune response nutritional interventions,\n○ outcomes (e.g., infection), and\n○ inflammation.']
S537-PMC4448820	PMC4448820	5/2015	S537-PMC4448820	['caption (table-wrap): table 6\n\neffects of Micronutrient supplementation on Immune function and vaccine responses (Human studies)1type of malnutrition and type of Immune functioneffects of supplementation on Immune System (reference)vitamin a\u2003Epithelial barrier function● high-dose vas above 6 mo of age decreases risk of death from infections such as measles and diarrheal diseases (290)● vas in the context of hiv infection or Lower Respiratory Tract infections HAS BEEN ASSOCIATED with adverse outcomes (105,263,290–292)● improved barrier function (105)● abnormal dual-Sugar (Lactulose, Mannitol) Intestinal permeability inversely CORRELATED with Serum Retinol (293) and PARTIALLY normalized by supplementation in va-deficient Individuals in SOME STUDIES (294) BUT NOT OTHERS (295,296)● increased symptomatology after high-dose vas during acute Lower Respiratory Tract infections REPORTED in SOME STUDIES (105) MAY INDICATE restored Mucus Production\u2003innate physiologic barriers● vas did not affect crp, saa, and/or agp concentrations among children with subclinical or clinical vad (297–299)● crp and agp did not change in men with low va stores given va (300)\u2003Macrophage function● increased Monocyte numbers (301)● decreased Tnf-Α concentrations in children (301) BUT the OPPOSITE in men (106)● decreased Ifn-Γ concentrations in children (302) but not in Pregnant women (303)● increased Il-10 concentrations in children (105,301) BUT no or an opposite effect in Adults (106,303,304)\u2003Neutrophil function● Neutrophil Phagocytosis of latex beads increased in va-deficient children given a single dose of Va (305)● Neutrophil Phagocytosis of E. Coli did not change in men with low Va stores given Va (300)\u2003Nk Cell function● an increase in Nk Cells in hiv-infected children supplemented with Va (105)● Nk Cell numbers did not change in men with low Va given supplemental Va; HOWEVER, there was a positive CORRELATION between Va stores and Peripheral Blood Nk Cells (300)\u2003T Cell function● increased Lymphocyte counts, particularly cd4 counts (105)● Cd4:Cd8 ratios were increased or unchanged by supplementation (306)● increase in Naive cd4 T Cells after supplementation; higher Memory Cd8, Cd45Ro (307)● higher Mitogen-induced Il-2, Il-4, and Tnf in response to supplementation (106)\u2003B Cell function● supplementation had no overall effect on Measles vaccine response (308) and a negative response in Individuals with baseline high titers (103)● no overall effect on oral polio vaccination● supplemented children increased Igg1 responses to dtp, minor igg3 response, no change in igg2 and igg4 (309)● no overall effect on bcg vaccine in Va-supplemented children, lower response in va-supplemented boys at 2 mo (310)● increased Antibody responses to some vaccines (Measles vaccine by 9 mo of age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response to ppd in boys (103) and hospitalized children (105)Zinc\u2003Epithelial barrier function● zn supplementation in children LED TO an improvement in the lactulose:Mannitol Excretion ratio in SOME (311) BUT NOT OTHER (312,313) STUDIES; ratio MAY improve in infected children without zn deficiency given supplemental zn (314)\u2003innate physiologic barriers ● zn-supplemented children had higher Serum Complement C3 (315)\u2003Nk Cell function● children with diarrhea supplemented with zn supplementation do not exhibit an increase in Nk Cells (316)● increased Nk Cell activity in the elderly (317)\u2003T Cell function● increased cd4+ cell count in aids patients (318)● increased Thymocyte count in Thymus (319)● increased thymulin activity (320)● no CONSISTENT effect of zn supplementation on dth to tb Antigen [reviewed in (103)]\u2003B Cell function● no effect of zn supplementation of mothers on Bcg response in children (321)\nagp, α1-acid Glycoprotein; bcg, bacille calmette-guérin; cd, cluster of differentiation; Cd45Ro , Cluster Of Differentiation Antigen 45 Ro; Crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, Serum Amyloid a; tb, tuberculosis; va, Vitamin A; vad, Vitamin A deficiency; vas, Vitamin A supplementation.']	[('INCOMPLETE_EVIDENCE', 463), ('SUPERFICIAL_RELATIONSHIP', 472), ('SUPERFICIAL_RELATIONSHIP', 633), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 763), ('INCOMPLETE_EVIDENCE', 882), ('INCOMPLETE_EVIDENCE', 894), ('INCOMPLETE_EVIDENCE', 913), ('INCOMPLETE_EVIDENCE', 917), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1267), ('ANOMALY_CURIOUS_FINDING', 1267), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1433), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1873), ('SUPERFICIAL_RELATIONSHIP', 1903), ('SUPERFICIAL_RELATIONSHIP', 3021), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3088), ('INCOMPLETE_EVIDENCE', 3088), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 3099), ('INCOMPLETE_EVIDENCE', 3123), ('INCOMPLETE_EVIDENCE', 3138), ('INCOMPLETE_EVIDENCE', 3633)]	23	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 42, 'micronutrient'), ('UBERON_0002405', 'immune system', 75, 'immune'), ('NCBITaxon_9606', 'Homo sapiens', 114, 'human'), ('UBERON_0002405', 'immune system', 162, 'immune'), ('UBERON_0002405', 'immune system', 207, 'immune system'), ('UBERON_0000483', 'epithelium', 242, 'Epithelial'), ('UBERON_0004905', 'articulation', 428, 'lower respiratory tract'), ('CHEBI_24870', 'ion', 571, 'sugar'), ('CHEBI_25098', 'lyxoside', 578, 'lactulose'), ('CHEBI_25169', 'mannoside', 589, 'mannitol'), ('UBERON_0000160', 'intestine', 599, 'intestinal'), ('UBERON_0001977', 'blood serum', 649, 'serum'), ('CHEBI_26536', 'retinoic acid', 655, 'retinol'), ('NCBITaxon_1', 'root', 729, 'individuals'), ('UBERON_0004905', 'articulation', 847, 'lower respiratory tract'), ('GO_0007498', 'mesoderm development', 935, 'mucus production'), ('UBERON_0000912', 'mucus', 935, 'mucus'), ('CL_0000235', 'macrophage', 1163, 'Macrophage'), ('CL_0000576', 'monocyte', 1194, 'monocyte'), ('PR_000000134', 'tumor necrosis factor alpha', 1228, 'TNF-α'), ('PR_000008920', 'interferon alpha-7', 1308, 'IFN-γ'), ('GO_0007565', 'female pregnancy', 1358, 'pregnant'), ('PR_000001470', 'interleukin-28B', 1390, 'IL-10'), ('UBERON_0007023', 'adult organism', 1465, 'adults'), ('CL_0000775', 'neutrophil', 1486, 'Neutrophil'), ('CL_0000775', 'neutrophil', 1507, 'Neutrophil'), ('GO_0007608', 'sensory perception of smell', 1507, 'Neutrophil'), ('GO_0006909', 'phagocytosis', 1518, 'phagocytosis'), ('CHEBI_37958', 'dye', 1604, 'VA'), ('CL_0000775', 'neutrophil', 1614, 'Neutrophil'), ('GO_0070231', 'T cell apoptotic process', 1614, 'Neutrophil phagocytosis'), ('NCBITaxon_10088', 'Mus <genus>', 1641, 'E. coli'), ('CHEBI_37958', 'dye', 1680, 'VA'), ('CHEBI_37958', 'dye', 1696, 'VA'), ('CL_0000623', 'natural killer cell', 1705, 'NK cell'), ('GO_0005634', 'nucleus', 1705, 'NK'), ('CL_0000623', 'natural killer cell', 1738, 'NK cells'), ('GO_0005634', 'nucleus', 1738, 'NK'), ('CHEBI_37958', 'dye', 1790, 'VA'), ('CL_0000623', 'natural killer cell', 1800, 'NK cell'), ('GO_0005634', 'nucleus', 1800, 'NK'), ('CHEBI_37958', 'dye', 1847, 'VA'), ('CHEBI_37958', 'dye', 1869, 'VA'), ('CHEBI_37958', 'dye', 1923, 'VA'), ('UBERON_0012101', 'perinatal stage', 1937, 'peripheral blood'), ('CL_0000623', 'natural killer cell', 1954, 'NK cells'), ('GO_0005634', 'nucleus', 1954, 'NK'), ('CL_0000084', 'T cell', 1969, 'T cell'), ('CL_0000542', 'lymphocyte', 1996, 'lymphocyte'), ('PR_000001204', 'C-C chemokine receptor type 8', 2046, 'CD4'), ('PR_000005170', 'CD37 molecule', 2050, 'CD8'), ('CL_0000898', 'naive T cell', 2127, 'naive ... T cells'), ('GO_0007613', 'memory', 2175, 'memory'), ('PR_000005170', 'CD37 molecule', 2182, 'CD8'), ('PR_000005170', 'CD37 molecule', 2187, 'CD45RO'), ('CHEBI_52290', 'mitogen', 2208, 'mitogen'), ('PR_000001470', 'interleukin-28B', 2224, 'IL-2'), ('PR_000001470', 'interleukin-28B', 2230, 'IL-4'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 2240, 'TNF'), ('CL_0000236', 'B cell', 2281, 'B cell'), ('NCBITaxon_33208', 'Metazoa', 2339, 'measles'), ('NCBITaxon_1', 'root', 2397, 'individuals'), ('GO_0071735', 'IgG immunoglobulin complex', 2519, 'IgG1'), ('CHEBI_37958', 'dye', 2633, 'VA'), ('GO_0042571', 'immunoglobulin complex, circulating', 2723, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 2760, 'measles'), ('CHEBI_27377', 'Unsym-bis(4*-chlorophenyl)ethylene', 2956, 'Zinc'), ('UBERON_0000483', 'epithelium', 2961, 'Epithelial'), ('CHEBI_25169', 'mannoside', 3060, 'mannitol'), ('GO_0007588', 'excretion', 3069, 'excretion'), ('UBERON_0001977', 'blood serum', 3287, 'serum'), ('PR_000004908', 'complement component C8 alpha chain', 3293, 'complement C3'), ('CL_0000623', 'natural killer cell', 3313, 'NK cell'), ('GO_0005634', 'nucleus', 3313, 'NK'), ('CL_0000623', 'natural killer cell', 3421, 'NK cells'), ('CL_0000623', 'natural killer cell', 3447, 'NK cell'), ('CL_0000084', 'T cell', 3485, 'T cell'), ('CL_0000893', 'thymocyte', 3562, 'thymocyte'), ('UBERON_0002370', 'thymus', 3581, 'thymus'), ('CHEBI_59132', 'antigen', 3686, 'antigen'), ('CL_0000236', 'B cell', 3714, 'B cell'), ('CHEBI_33250', 'atom', 3777, 'BCG'), ('CHEBI_17089', 'glycoprotein', 3821, 'glycoprotein'), ('PR_000005170', 'CD37 molecule', 3897, 'CD45RO'), ('PR_000011040', 'nuclear receptor coactivator 1', 3906, 'cluster of differentiation antigen 45 RO'), ('CHEBI_59132', 'antigen', 3933, 'antigen'), ('PR_000005890', 'crooked neck-like protein 1', 3948, 'CRP'), ('UBERON_0001977', 'blood serum', 4083, 'serum'), ('CHEBI_60425', 'amyloid fibril', 4089, 'amyloid'), ('CHEBI_27300', 'vitamin D', 4122, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4138, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 4165, 'vitamin A')]	0	['caption (table-wrap): table 6\n\neffects micronutrient supplementation  vaccine responses (human studies)1type malnutrition type  functioneffects supplementation  (reference)vitamin a\u2003epithelial function● high-dose vas 6 mo age decreases death infections measles diarrheal diseases (290)● vas context hiv infection respiratory tract infections outcomes (105,263,290–292)● (105)● abnormal dual-sugar (lactulose, mannitol) intestinal permeability serum retinol (293) normalized supplementation va-deficient individuals (294) (295,296)● symptomatology high-dose vas acute respiratory tract infections (105) restored mucus production\u2003innate physiologic barriers● vas crp, saa, and/or agp concentrations among children subclinical vad (297–299)● crp agp men va stores va (300)\u2003macrophage function● monocyte (301)● decreased tnf-α concentrations children (301) men (106)● decreased ifn-γ concentrations children (302) pregnant women (303)● il-10 concentrations children (105,301) adults (106,303,304)\u2003neutrophil function● neutrophil phagocytosis latex beads va-deficient children single dose va (305)● neutrophil phagocytosis e. coli men va stores va (300)\u2003nk cell function● increase nk cells hiv-infected children supplemented va (105)● nk cell men va supplemental va; however, positive va stores peripheral blood nk cells (300)\u2003t cell function● lymphocyte counts, cd4 counts (105)● cd4:cd8 ratios supplementation (306)● increase naive cd4 cells supplementation; higher memory cd8, cd45ro (307)● higher mitogen-induced il-2, il-4, tnf response supplementation (106)\u2003b cell function● supplementation measles vaccine response (308) response individuals baseline titers (103)● oral polio vaccination● supplemented children igg1 responses dtp, minor igg3 response, igg2 igg4 (309)● bcg vaccine va-supplemented children, response va-supplemented boys 2 mo (310)● antibody responses vaccines (measles vaccine 9 mo age, oral polio vaccine, type 1, hepatitis b vaccine, rabies vaccine) (103)● short-term diminished cellular response ppd boys (103) hospitalized children (105)zinc\u2003epithelial function● zn supplementation children lactulose:mannitol excretion ratio (311) (312,313) studies; ratio infected children zn supplemental zn (314)\u2003innate physiologic ● zn-supplemented children higher serum c3 (315)\u2003nk cell function● children diarrhea supplemented zn supplementation increase nk cells (316)● nk cell activity elderly (317)\u2003t cell function● cd4+ cell count patients (318)● thymocyte count thymus (319)● thymulin activity (320)● zn supplementation dth tb antigen [reviewed (103)]\u2003b cell function● zn supplementation mothers bcg response children (321)\nagp, α1-acid glycoprotein; bcg, bacille calmette-guérin; cd, cluster differentiation; cd45ro cluster antigen 45 ro; crp, c-reactive protein; dth, delayed-type hypersensitivity; dtp, diphtheria tetanus-pertussis; ppd, purified protein derivative; saa, serum amyloid a; tb, tuberculosis; va, vad,  deficiency; vas,  supplementation.']
S568-PMC4448820	PMC4448820	5/2015	S568-PMC4448820	['EFFECTS of vad/Vitamin A supplementation on Immune function and disease risk.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin A'), ('UBERON_0002405', 'immune system', 44, 'immune')]	0	['effects vad/ supplementation  disease risk.']
S569-PMC4448820	PMC4448820	5/2015	S569-PMC4448820	['as discussed by wg 1, Vad and Vitamin A supplementation AFFECT a range of innate and Adaptive Immune functions.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_16695', 'uridine 5*-monophosphate', 22, 'VAD'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin A'), ('GO_0019825', 'oxygen binding', 85, 'adaptive immune'), ('UBERON_0002405', 'immune system', 94, 'immune')]	0	['wg 1, vad  supplementation innate adaptive  functions.']
S574-PMC4448820	PMC4448820	5/2015	S574-PMC4448820	['the IMPORTANT EFFECTS of Vitamin A on Immune function are REFLECTED in the MANY community and clinical STUDIES that SHOWED that Vitamin A AFFECTS mortality and morbidity.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 138)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin A')]	0	['  community  mortality morbidity.']
S578-PMC4448820	PMC4448820	5/2015	S578-PMC4448820	['one POSSIBLE EXPLANATION for the APPARENT lack of benefit of Vitamin A supplementation below 6 mo of age is that infants in SUCH studies are PROTECTED from infection by maternally derived Immune factors (e.g., Serum Igg, factors in Breast Milk) to a greater degree than are older infants.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 33), ('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('UBERON_0002405', 'immune system', 188, 'immune'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('UBERON_0001348', 'brown adipose tissue', 232, 'breast milk')]	0	['one  supplementation 6 mo age infants infection maternally  (e.g., serum igg, breast milk) degree older infants.']
S593-PMC4448820	PMC4448820	5/2015	S593-PMC4448820	['HOWEVER, the EFFECTS of Vitamin A supplementation on the Immune System MAY lead TO variable clinical outcomes, DEPENDING ON the nature of the Immune Response NEEDED to combat the infecting pathogens.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin A'), ('UBERON_0002405', 'immune system', 57, 'immune system'), ('GO_0006955', 'immune response', 142, 'immune response'), ('UBERON_0002405', 'immune system', 142, 'immune')]	0	['however,  supplementation  outcomes, nature  response combat infecting pathogens.']
S782-PMC4448820	PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]	0	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● vad\n●  supplementation inflammation inflammatory markers\n● mechanisms behind outcomes result   responses\n●  supplementation neonates infants <6 mo\n● zinc status vaccine response\n● zinc–vaccine response (age, sex, degree zinc deficiency, etc.)']
S1041-PMC4448820	PMC4448820	5/2015	S1041-PMC4448820	['● low Vitamin D concentrations MAY increase risk of Allergic sensitization leading to abnormalities in the Allergic Immune Response (582).']	[('INCOMPLETE_EVIDENCE', 31)]	1	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0040011', 'locomotion', 52, 'allergic'), ('GO_0002250', 'adaptive immune response', 107, 'allergic immune response'), ('UBERON_0002405', 'immune system', 116, 'immune')]	0	['●  concentrations increase allergic sensitization abnormalities allergic  response (582).']
S1194-PMC4448820	PMC4448820	5/2015	S1194-PMC4448820	['this phenomenon SHOULD BE evaluated closely, particularly in light of the EXPANDING INTEREST in Vitamin D supplementation to boost Immune function and for use in numerous conditions including hiv and other infections.']	[('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 74)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0002405', 'immune system', 131, 'immune')]	0	['closely,  supplementation boost  conditions hiv infections.']
S1516-PMC4448820	PMC4448820	5/2015	S1516-PMC4448820	['as outlined by wgs 1 and 2, an EXPANDING body of EVIDENCE ATTESTS to the IMPORTANCE of Vitamin D to Immune function and the inflammatory Response, with potential therapeutic applications for acute and chronic infectious and inflammatory diseases (790).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 58), ('IMPORTANT_CONSIDERATION', 73)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('GO_0060033', 'anatomical structure regression', 137, 'response')]	0	['wgs 2,   inflammatory response, applications acute chronic infectious inflammatory diseases (790).']
S39-PMC4488777	PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]	0	[' ovarian granulosa cells steroidogenesis,  regulation, 1-α-hydroxylase vdr receptors deciduae, placentas, ovaries, endometriums pituitary glands, metabolites  1,25[oh]2d 24,25[oh]2d tissues [14,15,16,17,18].']
S161-PMC4488777	PMC4488777	5/2015	S161-PMC4488777	['as STATED by the authors, the results of their study PROVE an increased Production Of active form Of Vitamin D in the first trimester Decidua, which Modulates reactions in a Paracrine manner between the mother’s and the Embryo’s Immune System during the Implantation.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 53)]	2	[('GO_0040007', 'growth', 72, 'production of ... of vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002450', 'decidua', 134, 'decidua'), ('GO_0065007', 'biological regulation', 149, 'modulates'), ('GO_0038001', 'paracrine signaling', 174, 'paracrine'), ('UBERON_0000922', 'embryo', 220, 'embryo'), ('UBERON_0002405', 'immune system', 229, 'immune system'), ('GO_0007566', 'embryo implantation', 254, 'implantation')]	0	['authors, production form  trimester decidua, reactions paracrine manner mother’s embryo’s  implantation.']
S68-PMC4514967	PMC4514967	12/2014	S68-PMC4514967	['the predominant EFFECTS of Vitamin A on the Immune System are THOUGHT TO be mediated by Retinoic Acid (ra).']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 62)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('UBERON_0002405', 'immune system', 44, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid')]	0	['  retinoic acid (ra).']
S69-PMC4514967	PMC4514967	12/2014	S69-PMC4514967	['ra is generated from dietary Vitamin A through a number of steps, the final being conversion of Retinal to ra by Retinal dehydrogenase.53ALTHOUGH various cell types can perform this transformation, apcs, specifically those at Tissue sites like the Intestine and skin, are specialized in the provision of ra for Modulation Of Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 135)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('UBERON_0000966', 'retina', 96, 'retinal'), ('UBERON_0000966', 'retina', 113, 'retinal'), ('UBERON_0000479', 'tissue', 226, 'tissue'), ('UBERON_0000160', 'intestine', 248, 'intestine'), ('GO_0006880', 'intracellular sequestering of iron ion', 311, 'modulation of immune responses'), ('UBERON_0002405', 'immune system', 325, 'immune')]	0	['ra generated dietary  steps, final conversion retinal ra retinal dehydrogenase.53although cell perform transformation, apcs, tissue sites intestine skin, specialized provision ra  responses.']
S74-PMC4514967	PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]	0	['first, ra synergize activity tgf-β induced foxp3+tregcells,55,59–61although frequency tregcells –deficient mice.62second, ra mount  responses infection organisms toxoplasma gondii .62third, –deficient mice th17 cells63,64and display th1 th17 responses t. gondii infection oral administration escherichia coli heat-labile enterotoxin.62vitamin conditioning dcs promoting stereotypical phenotypic intestinal cd103+dcs,58highlighting cell  plays immunity.']
S79-PMC4684854	PMC4684854	12/2015	S79-PMC4684854	['this research FOUND that lower Vitamin D levels were ASSOCIATED with Immune Dysregulation in a NUMBER OF ways, including differences in indices involving Natural Killer Cells, various cytokines, and certain Regulatory proteins, when compared to those with sufficient Vitamin D levels [50].']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0001774', 'microglial cell activation', 69, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('CL_0000623', 'natural killer cell', 154, 'natural killer cells'), ('GO_0065007', 'biological regulation', 207, 'regulatory'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]	0	[' levels  dysregulation ways, indices natural killer cells, cytokines, proteins,  levels [50].']
S85-PMC4684854	PMC4684854	12/2015	S85-PMC4684854	['NUMEROUS STUDIES have also CORRELATED low levels of Vitamin D with the development of Preeclampsia [52,53,55,56], PERHAPS through Immune mechanisms involving Antiphospholipid Antibody [51], and/or inflammatory mechanisms involving cytokines [56].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 86, 'preeclampsia'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('CHEBI_16240', 'hydrogen peroxide', 158, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibody')]	0	['numerous levels  preeclampsia [52,53,55,56],  mechanisms antiphospholipid antibody [51], and/or inflammatory mechanisms cytokines [56].']
S110-PMC4684854	PMC4684854	12/2015	S110-PMC4684854	['a RECENT body of work has begun TO SUGGEST that lower Gestational Vitamin D levels MAY also be ASSOCIATED with higher rates of pediatric atopic disease [77], food sensitivities [78], atopic dermatitis [79], eczema [80], asthma [81], impaired Lung function [82], allergic disease [83], and other conditions frequently characterized by a hypersensitive Immune state.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 95)]	5	[('GO_0007565', 'female pregnancy', 54, 'gestational'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002048', 'lung', 242, 'lung'), ('UBERON_0002405', 'immune system', 351, 'immune')]	0	['gestational  levels higher rates pediatric atopic disease [77], food sensitivities [78], atopic dermatitis [79], eczema [80], asthma [81], lung [82], allergic disease [83], conditions hypersensitive  state.']
S111-PMC4684854	PMC4684854	12/2015	S111-PMC4684854	['it APPEARS that fetal Vitamin D levels MAY play a modulating ROLE in Immune functions INVOLVED in atopic disorders.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 86)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 69, 'immune')]	0	['fetal  levels play  functions atopic disorders.']
S112-PMC4684854	PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]	0	['hypersensitivity outcomes children born mothers assorted xenobiotics pregnancy [84–89], however,  dysregulation hypersensitivity gestational chemical toxicants play impairing  uptake, renal synthesis, assimilation [25,90] inducing  hypersensitivity mechanisms [91].']
S0-PMC4691762	PMC4691762	12/2015	S0-PMC4691762	['vitality trial: protocol for a randomised controlled trial to establish the ROLE of Postnatal Vitamin D supplementation in infant Immune health\n\nabstract\n\nintroduction\nPostnatal Vitamin D supplementation MAY be ASSOCIATED with a reduction in Ige-mediated Food allergy, Lower Respiratory Tract infections and improved bone health.']	[('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 211)]	3	[('GO_0007567', 'parturition', 84, 'postnatal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0007567', 'parturition', 168, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007630', 'jump response', 242, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 242, 'IgE'), ('CHEBI_33290', 'food', 255, 'food'), ('GO_0007631', 'feeding behavior', 255, 'food'), ('UBERON_0004905', 'articulation', 269, 'lower respiratory tract')]	0	['vitality trial: protocol randomised postnatal  supplementation infant  health\n\nabstract\n\nintroduction\npostnatal  supplementation reduction ige-mediated food allergy, respiratory tract infections bone health.']
S15-PMC4691762	PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]	0	['introduction\nvitamin play infant  health, life  childhood diseases food allergy1lower respiratory infections (lris)2and eczema.3a marked  life modern populations rise allergic diseases food allergy eczema.']
S17-PMC4691762	PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]	0	['recent  birth infancy food allergy6and eczema.7in addition food allergy eczema higher equator person resides,  (through ultraviolet (uv) exposure) play aberrant  life increase food allergy eczema.3food allergy manifestations  deviation,8but eczema infancy asthma life.9\nvitamin supplementation year life lris10and recovery infants acute bronchiolitis.11since life wheezy lris longer term respiratory outcomes asthma12understanding  life respiratory diseases important.']
S106-PMC4691762	PMC4691762	12/2015	S106-PMC4691762	['we will not be monitoring Serum 25(Oh)D for safety reasons nor considering the association between 25(Oh)D and outcome frequency given that 400\u2005Iu HAS BEEN SHOWN to be SAFE in term babies,1926preterm infants27and is the current RECOMMENDED dose in the usa, canada, the uk and europe.18\n\ndiscussion\nthe results of the vitality trial will determine WHETHER Vitamin D supplementation has a ROLE in optimising infant Immune health in the first year of Life, reducing the risk of allergic disease and Respiratory diseases.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 168), ('FUTURE_WORK', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 347), ('SUPERFICIAL_RELATIONSHIP', 387)]	5	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 32, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 99, '25(OH)D'), ('CHEBI_17883', 'hydrogen chloride', 144, 'IU'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin D'), ('UBERON_0002405', 'immune system', 413, 'immune'), ('UBERON_0000104', 'life cycle', 448, 'life'), ('UBERON_0001004', 'respiratory system', 496, 'respiratory')]	0	['serum 25(oh)d 25(oh)d outcome frequency 400\u2005iu term babies,1926preterm infants27and dose usa, canada, uk europe.18\n\ndiscussion\nthe results  supplementation optimising infant  year life, reducing allergic disease respiratory diseases.']
S114-PMC4691762	PMC4691762	12/2015	S114-PMC4691762	['there are several PLAUSIBLE biological mechanisms for the ROLE of Vitamin D in early infant, Immune health.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0002405', 'immune system', 93, 'immune')]	0	['biological mechanisms  infant,  health.']
S118-PMC4691762	PMC4691762	12/2015	S118-PMC4691762	['it acts by inducing Antimicrobial peptides in Epithelial Cells, Neutrophils and Macrophages28And increases transcription of the innate Immune protein (hcap-18) which is capable of killing a wide variety of Viral and bacterial pathogens.29THESE FINDINGS are SUPPORTED by the observation that Vitamin D receptor polymorphisms (which decrease the bioavailability of Vitamin D to the cell) are ASSOCIATED with more SEVERE bronchiolitis30and that defective Control Of Vitamin D receptor-Mediated Cell Signalling PREDISPOSES to SEVERE Respiratory syncytial Virus bronchiolitis.31\n\nconclusions\ninternational enthusiasm for supplemental Vitamin D has OUTPACED AVAILABLE EVIDENCE on its EFFECTIVENESS32AND in fact ARGUMENT for routine supplementation is in equipoise.']	[('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 411), ('SUPERFICIAL_RELATIONSHIP', 507), ('IMPORTANT_CONSIDERATION', 522), ('ANOMALY_CURIOUS_FINDING', 643), ('ANOMALY_CURIOUS_FINDING', 643), ('INCOMPLETE_EVIDENCE', 652), ('SUPERFICIAL_RELATIONSHIP', 678), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 705)]	11	[('CHEBI_65381', 'albizoside C', 20, 'antimicrobial'), ('CL_0000066', 'epithelial cell', 46, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 46, 'epithelial'), ('CL_0000775', 'neutrophil', 64, 'neutrophils'), ('CL_0000091', 'Kupffer cell', 80, 'macrophages28and'), ('UBERON_0002405', 'immune system', 135, 'immune'), ('NCBITaxon_1', 'root', 206, 'viral'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('GO_0060070', 'canonical Wnt signaling pathway', 452, 'control of ... -mediated cell signalling'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 529, 'respiratory'), ('NCBITaxon_1', 'root', 551, 'virus'), ('CHEBI_27300', 'vitamin D', 629, 'vitamin D')]	0	['inducing antimicrobial peptides epithelial cells, neutrophils macrophages28and transcription innate  protein (hcap-18) capable killing viral bacterial pathogens.29these  receptor polymorphisms (which decrease bioavailability  cell) bronchiolitis30and defective  receptor-mediated cell signalling respiratory syncytial virus bronchiolitis.31\n\nconclusions\ninternational supplemental  routine supplementation equipoise.']
S119-PMC4691762	PMC4691762	12/2015	S119-PMC4691762	['if FOUND to be both efficacious and cost-effective, Vitamin D infant supplementation would provide a readily available, low harm INTERVENTION that would optimise infant Immune health in the first year of Life and significantly reduce the population BURDEN of allergic disease.']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 129), ('IMPORTANT_CONSIDERATION', 249)]	4	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0002405', 'immune system', 169, 'immune'), ('UBERON_0000104', 'life cycle', 204, 'life')]	0	['cost-effective,  infant supplementation available, harm optimise infant  year life population allergic disease.']
S38-PMC4785305	PMC4785305	3/2016	S38-PMC4785305	['they ASSESSED the EFFECT of various doses of Vitamin D on the 25(Oh)D level, Immune function and Periodontal disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('UBERON_0002405', 'immune system', 77, 'immune'), ('UBERON_0001758', 'periodontium', 97, 'periodontal')]	0	['doses  25(oh)d level,  periodontal disease.']
S51-PMC4800340	PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]	0	['results dna methylation regions genes t-cell balance th1 th2 period life mechanisms allergic disease development.73\n\nepigenetic nutrients\nalthough prenatal folate, n-3 pufa,   programming suggested,3474only epigenetic nutrients biological allergic diseases.']
S169-PMC4846845	PMC4846845	4/2016	S169-PMC4846845	['a RECENT STUDY has FOUND ASSOCIATIONS between Vitamin D levels in maternal and Cord Blood and Immune Cell type proportions, as well as Placental Expression of Immune System related Genes [130].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 79, 'cord'), ('UBERON_0000178', 'blood', 84, 'blood'), ('CL_0000738', 'leukocyte', 94, 'immune cell'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0001987', 'placenta', 135, 'placental'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0002405', 'immune system', 159, 'immune system'), ('SO_0000704', 'gene', 181, 'genes')]	0	[' levels maternal cord blood  cell type proportions, placental expression  genes [130].']
S104-PMC4859539	PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]	0	['additionally, circulating cathelicidin concentration happening cellular level, regard, cathelicidin mrna expression  cells tissue ’s long-term cathelicidin system.']
S0-PMC4889866	PMC4889866	5/2016	S0-PMC4889866	['maternal Vitamin D level is ASSOCIATED with Viral toll-like receptor triggered Il-10 response but not the risk of infectious diseases in infancy\n\nabstract\nreports on the EFFECT of Prenatal Vitamin D status on fetal Immune Development and infectious diseases in childhood are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 275)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Viral'), ('PR_000001470', 'interleukin-28B', 79, 'IL-10'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0001822', 'kidney development', 215, 'immune development'), ('UBERON_0002405', 'immune system', 215, 'immune')]	0	['maternal vitamin viral toll-like receptor triggered il-10 response infectious diseases infancy\n\nabstract\nreports prenatal  status fetal  infectious diseases childhood limited.']
S13-PMC4889866	PMC4889866	5/2016	S13-PMC4889866	['HENCE, AS a potent Immune modulator, Vitamin D WAS shown to be ASSOCIATED with childhood asthma and allergic diseases [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 7), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0002405', 'immune system', 19, 'immune'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]	0	['hence, potent  modulator,  childhood asthma allergic diseases [4–6].']
S15-PMC4889866	PMC4889866	5/2016	S15-PMC4889866	['GIVEN the IMPORTANT Immune Modulatory ROLE of Vitamin D, the LINK between toll-like receptors- (tlrs-) mediated Innate Immunity and Vitamin D DESERVES in-depth INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 160)]	6	[('GO_0051452', 'intracellular pH reduction', 20, 'immune modulatory'), ('UBERON_0002405', 'immune system', 20, 'immune'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0045087', 'innate immune response', 112, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]	0	['given  modulatory toll-like receptors- (tlrs-) innate immunity  in-depth investigation.']
S16-PMC4889866	PMC4889866	5/2016	S16-PMC4889866	['STUDIES HAVE SHOWN Vitamin D to downregulate tlr Expression in order to dampen Immune Cytokine response in multiple basic science MODELS [11–13].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0010467', 'gene expression', 49, 'expression'), ('GO_0002225', 'positive regulation of antimicrobial peptide production', 79, 'immune cytokine'), ('UBERON_0002405', 'immune system', 79, 'immune')]	0	['studies  downregulate tlr expression dampen  cytokine response science [11–13].']
S20-PMC4889866	PMC4889866	5/2016	S20-PMC4889866	['furthermore, VERY FEW STUDIES address the IMPACT of Prenatal Vitamin D status on tlr-RELATED Innate Immune Response in neonatal infants.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0045087', 'innate immune response', 93, 'innate immune response'), ('UBERON_0002405', 'immune system', 100, 'immune')]	0	['furthermore, prenatal  status tlr-related innate  response neonatal infants.']
S21-PMC4889866	PMC4889866	5/2016	S21-PMC4889866	['because of the APPARENT IMPORTANCE of Vitamin D in Immune Development, we AIMED TO INVESTIGATE the EFFECT of maternal and/or cord Vitamin D level on tlr-triggered cytokine response in neonates at time of Birth and disease outcome in early childhood.']	[('ANOMALY_CURIOUS_FINDING', 15), ('IMPORTANT_CONSIDERATION', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 99)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0001822', 'kidney development', 51, 'immune development'), ('UBERON_0002405', 'immune system', 51, 'immune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007567', 'parturition', 204, 'birth')]	0	['  development, maternal and/or cord  tlr-triggered cytokine response neonates birth disease outcome childhood.']
S81-PMC4889866	PMC4889866	5/2016	S81-PMC4889866	['PRELIMINARY analysis was also performed on maternal innate Immune function; the result SHOWED no correlation between maternal Vitamin D status and cytokine response to tlr ligands in maternal Mononuclear cells (supplement 1) (see supplementary material available online athttp://dx.doi.org/10.1155/2016/8175898).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 87)]	2	[('UBERON_0002405', 'immune system', 59, 'immune'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CL_0000100', 'motor neuron', 192, 'mononuclear'), ('GO_0031097', 'medial cortex', 192, 'mononuclear')]	0	['preliminary maternal innate  function; result maternal  status cytokine response tlr ligands maternal mononuclear cells (supplement 1) (see supplementary material online athttp://dx.doi.org/10.1155/2016/8175898).']
S90-PMC4889866	PMC4889866	5/2016	S90-PMC4889866	['DESPITE extensive investigations on Vitamin D, its ROLE in Neonatal Immune Development and health outcome REMAINS INCONSISTENT.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 59, 'neonatal'), ('GO_0001822', 'kidney development', 68, 'immune development'), ('UBERON_0002405', 'immune system', 68, 'immune')]	0	['despite neonatal  outcome inconsistent.']
S105-PMC4889866	PMC4889866	5/2016	S105-PMC4889866	['AS a potent Anti-inflammatory Immune Modulator, STUDIES HAVE SHOWN Vitamin D to downregulate tlr Expression in Monocytes resulting in reduced downstream Cytokine Production [11,13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 56)]	3	[('CHEBI_67437', 'Euparin', 12, 'anti-'), ('UBERON_0002405', 'immune system', 30, 'immune'), ('CHEBI_33220', '3-monobromobisphenol A', 37, 'modulator'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0010467', 'gene expression', 97, 'expression'), ('CL_0000576', 'monocyte', 111, 'monocytes'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 153, 'cytokine production')]	0	['potent anti-inflammatory  modulator,  downregulate tlr expression monocytes resulting cytokine production [11,13].']
S118-PMC4889866	PMC4889866	5/2016	S118-PMC4889866	['these INCONSISTENT OBSERVATIONS POINT to the COMPLICATED ROLE of Vitamin D in the Immune modulation and disease process.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 57)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]	0	['  disease process.']
S131-PMC4889866	PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]	0	['cord  maternal  status, fetal  cytokine response distinctive.']
S394-PMC4896250	PMC4896250	4/2016	S394-PMC4896250	['a28 tgfβ1 level is ASSOCIATED with vdr Gene polymorphism in children with allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute of nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova – institute of nutrition, russia\nbackground: Vitamin D Receptor (Vdr) is Intracellulary located on the cells Of the Immune System and is INVOLVED in the Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 412)]	2	[('SO_0000704', 'gene', 39, 'gene'), ('CHEBI_27300', 'vitamin D', 320, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 320, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 340, 'VDR'), ('GO_0005622', 'intracellular anatomical structure', 348, 'intracellulary'), ('CL_0000024', 'oogonial cell', 384, 'of'), ('UBERON_0002405', 'immune system', 391, 'immune system'), ('CL_0000034', 'stem cell', 398, 'system'), ('GO_0006955', 'immune response', 428, 'immune response'), ('UBERON_0002405', 'immune system', 428, 'immune')]	0	['a28 tgfβ1 vdr gene polymorphism children allergy diseases\n\ntatiana sentsova1, ilya vorozhko1, olga chernyak1, vera revyakina1, anna timopheeva1, andrey donnikov2\n\n1institute nutrition;2dna-technology, jsc\n\ncorrespondence: tatiana sentsova institute nutrition, russia\nbackground:  receptor (vdr) intracellulary located cells   response.']
S4149-PMC4896250	PMC4896250	4/2016	S4149-PMC4896250	['emerging EVIDENCE has IMPLICATED Vitamin D as a CRITICAL REGULATOR of Immunity, playing a ROLE in both the innate and cell-Mediated Immune Systems.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 22), ('IMPORTANT_CONSIDERATION', 48), ('SUPERFICIAL_RELATIONSHIP', 57), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007566', 'embryo implantation', 70, 'immunity'), ('GO_0007127', 'meiosis I', 123, 'mediated immune'), ('UBERON_0002405', 'immune system', 132, 'immune systems')]	0	['emerging  immunity, playing innate cell-mediated .']
S6538-PMC4896250	PMC4896250	4/2016	S6538-PMC4896250	['conclusions: these results SUGGEST that Vitamin D MIGHT Modulate mediators INVOLVED in Immune Responses in crs.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 56, 'modulate'), ('GO_0006955', 'immune response', 87, 'immune responses'), ('UBERON_0002405', 'immune system', 87, 'immune')]	0	['conclusions: results   responses crs.']
S9520-PMC4896250	PMC4896250	4/2016	S9520-PMC4896250	['Epidermal barrier injury and Dysregulatory of Immune System COULD BE induced by Vitamin D. the AIM of STUDY was TO REVEAL RELATION in between of Serum level of 25-hydroxyvitamin d with atopic dermatitis occurrence and severity in children.']	[('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 102), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 122)]	6	[('UBERON_0007376', 'outer epithelium', 0, 'Epidermal'), ('GO_0007631', 'feeding behavior', 29, 'dysregulatory'), ('UBERON_0002405', 'immune system', 46, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 53, 'system'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum')]	0	['epidermal injury dysregulatory  induced . serum 25-hydroxyvitamin atopic dermatitis occurrence children.']
S55-PMC4918713	PMC4918713	6/2015	S55-PMC4918713	['Animal STUDIES HAVE SHOWN that neonatal copper deficiency is ASSOCIATED with developmental abnormalities and altered Thyroid and Immune function.38\na similar DIFFERENTIAL EFFECT between mother and fetus is also SEEN in Vitamin A Metabolism.']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 211)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002405', 'immune system', 129, 'immune'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 219, 'vitamin A metabolism'), ('PR_000004370', 'asialoglycoprotein receptor 2', 227, 'A')]	0	['animal neonatal copper developmental abnormalities altered thyroid  function.38\na mother fetus  metabolism.']
S106-PMC4934634	PMC4934634	11/2015	S106-PMC4934634	['cathelicidins, Antimicrobial peptides that can defend against pathogens, are up regulated by Vitamin D. vdr can bind to response elements Of the Human Cathelicidin peptide Gene (Cathelicidin Antimicrobial peptide; camp) increasing the Killing ability of Innate Immune Cells, Macrophages, THUS strengthening the innate Immune System’s response [41].']	[('PROBABLE_UNDERSTANDING', 288)]	1	[('CHEBI_65381', 'albizoside C', 15, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('SO_0001467', 'RST', 138, 'of'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('PR_000006009', 'alpha-catulin', 151, 'cathelicidin'), ('SO_0000704', 'gene', 172, 'gene'), ('CHEBI_3364', 'Canthiumine', 178, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 178, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 191, 'antimicrobial'), ('GO_0007601', 'visual perception', 235, 'killing'), ('CL_0002088', 'interstitial cell of Cajal', 254, 'innate immune cells'), ('GO_0044409', 'entry into host', 254, 'innate immune cells'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('CL_0000235', 'macrophage', 275, 'macrophages'), ('UBERON_0002405', 'immune system', 318, 'immune system')]	0	['cathelicidins, antimicrobial peptides defend pathogens, . vdr bind response elements human cathelicidin peptide gene (cathelicidin antimicrobial peptide; camp) killing ability innate  cells, macrophages, innate ’s response [41].']
S143-PMC4934634	PMC4934634	11/2015	S143-PMC4934634	['anti-inflammatory and Immune modulating properties of Vitamin D are POSTULATED to CONTRIBUTE to the protective mechanism against Preeclampsia.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('UBERON_0002405', 'immune system', 22, 'immune'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 129, 'preeclampsia')]	0	['anti-inflammatory  properties  preeclampsia.']
S15-PMC4944244	PMC4944244	7/2016	S15-PMC4944244	['lack of Vitamin D MAY have an adverse health EFFECTS including death, cancer, Cardiovascular disease, impaired Immune function and Glucose Metabolism [4].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 78, 'cardiovascular'), ('UBERON_0002405', 'immune system', 111, 'immune'), ('CHEBI_17234', 'glucose', 131, 'glucose'), ('GO_0006006', 'glucose metabolic process', 131, 'glucose metabolism')]	0	['lack  death, cancer, cardiovascular disease,  glucose metabolism [4].']
S15-PMC4979151	PMC4979151	8/2016	S15-PMC4979151	['maternal Vitamin D status during Pregnancy MAY AFFECT the fetal Immune System and CONTRIBUTE to the risk of development of Immune-mediated diseases and infection in the offspring.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002405', 'immune system', 64, 'immune system'), ('UBERON_0002405', 'immune system', 123, 'immune')]	0	['maternal  status pregnancy fetal  -mediated diseases infection offspring.']
S17-PMC4979151	PMC4979151	8/2016	S17-PMC4979151	['VARIOUS in vitro STUDIES of the EFFECTS of Vitamin D on the T-Cell phenotype HAVE SHOWN that active Vitamin D3(1,25(Oh)2D3) suppresses Production Of Th1 Cytokines and Il-17 [12,13] and promotes Th2 Responses [14,15] and T Regulatory Cells (Treg) to maintain a balance and prevent exacerbated Immune Responses [16,17].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CL_0000084', 'T cell', 60, 'T-cell'), ('CHEBI_33279', 'vitamin D5', 100, 'vitamin D3'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 112, ',25(OH)2D3'), ('GO_0006915', 'apoptotic process', 135, 'production of Th1 cytokines'), ('PR_000001470', 'interleukin-28B', 167, 'IL-17'), ('GO_0007596', 'blood coagulation', 194, 'Th2 responses'), ('CL_0000902', 'induced T-regulatory cell', 220, 'T regulatory cells'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 220, 'T regulatory'), ('CL_0000901', 'Tr1 cell', 240, 'Treg'), ('GO_0006955', 'immune response', 292, 'immune responses'), ('UBERON_0002405', 'immune system', 292, 'immune')]	0	['various  t-cell phenotype vitamin d3(1,25(oh)2d3) suppresses production th1 cytokines il-17 [12,13] th2 responses [14,15] cells (treg) maintain balance exacerbated  responses [16,17].']
S117-PMC4979151	PMC4979151	8/2016	S117-PMC4979151	['there is a SCARCITY of in vivo data in Humans during Pregnancy SHOWING EFFECTS of Vitamin D supplementation on neonatal Immune function.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('NCBITaxon_9606', 'Homo sapiens', 39, 'humans'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002405', 'immune system', 120, 'immune')]	0	['vivo humans pregnancy  supplementation neonatal  function.']
S160-PMC4979151	PMC4979151	8/2016	S160-PMC4979151	['it HAS BEEN REPORTED that the anti-inflammatory benefits of Vitamin D and optimal Immune function was SEEN in Individuals with 25(Oh)D3As high as 100\xa0nmol/l [30,45].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 102)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune'), ('NCBITaxon_1', 'root', 110, 'individuals'), ('CHEBI_73376', 'Ala-Met-Ser-Arg', 127, '25(OH)D3as'), ('PR_000036866', 'neurexin-3-beta', 127, '25(OH)D3as')]	0	['anti-inflammatory   individuals 25(oh)d3as 100\xa0nmol/l [30,45].']
S13-PMC4997421	PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]	0	['introduction\nvitamin nutrient throughout lifecycle; however, periods cells proliferate rapidly differentiate, pregnancy.adequate  status mother fetal growth, morphogenesis, maturation organ systems, lungs, eyes [1,2].']
S15-PMC4997421	PMC4997421	8/2016	S15-PMC4997421	['maternal Vitamin A deficiency also has SERIOUS repercussions for the newborn and is ASSOCIATED with depressed Immune function and higher morbidity and mortality due to infections [1], low Birth weight [6], Diaphragmatic hernia [7], bronchopulmonary dysplasia and other Respiratory disease [8,9,10].']	[('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('UBERON_0002405', 'immune system', 110, 'immune'), ('GO_0007567', 'parturition', 188, 'birth'), ('UBERON_0001103', 'diaphragm', 206, 'diaphragmatic'), ('UBERON_0001004', 'respiratory system', 269, 'respiratory')]	0	['maternal  newborn depressed  higher morbidity mortality infections [1], birth [6], diaphragmatic hernia [7], bronchopulmonary dysplasia respiratory disease [8,9,10].']
S69-PMC5014971	PMC5014971	8/2016	S69-PMC5014971	['respondents were CONCERNED about Vitamin D deficiency and osteoporosis (91.1%) and bone fractures (88.1%), but less CONCERNED about other POSSIBLE sequelae of Vitamin D deficiency such as a weakened Immune System (32.7%), Colon cancer (27.7%), Cardiovascular disease (23.8%), impaired glucose Metabolism (22.8%), vulnerability to preeclampsia (22.8%), increased risk of small-for-Gestational-age infant (21.8%), vulnerability to Preterm Labor (19.8%), Breast cancer (14.9%), hypertension (12.9%), and infertility (10.9%).']	[('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('UBERON_0002405', 'immune system', 199, 'immune system'), ('UBERON_0001155', 'colon', 222, 'colon'), ('UBERON_0004535', 'cardiovascular system', 244, 'cardiovascular'), ('GO_0008152', 'metabolic process', 293, 'metabolism'), ('GO_0007565', 'female pregnancy', 380, 'gestational'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 429, 'preterm labor'), ('UBERON_0000310', 'breast', 452, 'breast')]	0	['respondents  osteoporosis (91.1%) bone fractures (88.1%), sequelae   (32.7%), colon cancer (27.7%), cardiovascular disease (23.8%), glucose metabolism (22.8%), preeclampsia (22.8%), small-for-gestational-age infant (21.8%), preterm labor (19.8%), breast cancer (14.9%), hypertension (12.9%), infertility (10.9%).']
S21-PMC5064894	PMC5064894	10/2016	S21-PMC5064894	['Vitamin D HAS BEEN SHOWN to Modulate the Innate Immune Response in Lung Epithelial Cells [6,7], and Antimicrobial peptides induced by Vitamin D MAY have antiviral EFFECTS BASED on observed activity against Herpes Simplex Virus-1 (Hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] and vaccinia [11].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 171)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0065007', 'biological regulation', 28, 'modulate'), ('GO_0045087', 'innate immune response', 41, 'innate immune response'), ('UBERON_0002405', 'immune system', 48, 'immune'), ('CL_0000082', 'epithelial cell of lung', 67, 'lung epithelial cells'), ('UBERON_0000115', 'lung epithelium', 67, 'lung epithelial'), ('CHEBI_65381', 'albizoside C', 100, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000008476', 'orexin', 206, 'herpes simplex virus'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 230, 'HSV-1')]	0	['vitamin innate  response lung epithelial cells [6,7], antimicrobial peptides induced  antiviral activity herpes simplex virus-1 (hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] vaccinia [11].']
S126-PMC5084016	PMC5084016	10/2016	S126-PMC5084016	['in the first stage of Pregnancy, Vitamin D (mainly Vitamin D3, the predominant form in the maternal Blood) is INVOLVED in the Regulation Of Cytokine Metabolism and in the Modulation Of the Immune System, thereby contributing to the Embryo Implantation and Regulating the secretion of several hormones.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 51, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'Vitamin D3'), ('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 126, 'regulation of'), ('GO_0009690', 'cytokinin metabolic process', 140, 'cytokine metabolism'), ('GO_0002022', 'detection of dietary excess', 171, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 189, 'immune system'), ('GO_0007601', 'visual perception', 232, 'embryo'), ('UBERON_0000922', 'embryo', 232, 'embryo'), ('GO_0007566', 'embryo implantation', 239, 'implantation'), ('GO_0065007', 'biological regulation', 256, 'regulating')]	0	['pregnancy,  (mainly vitamin d3, form maternal blood) cytokine metabolism embryo implantation secretion hormones.']
S27-PMC5129897	PMC5129897	10/2016	S27-PMC5129897	['materials and methods\npublications on the RELATIONS between 25(Oh)D concentrations and health outcomes were obtained LARGELY by searchingpubmed.govandscholar.google.comfor terms such as Vitamin D, 25-Hydroxyvitamin D, meta-analysis, Back and Spine disorders, cancer, Cardiovascular disease, Immune System, osteoporosis, Respiratory infection, economic BURDEN, canada, cost, season, mortality, incidence , and risk .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 352)]	3	[('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 60, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 197, '25-hydroxyvitamin D'), ('UBERON_0001137', 'dorsum', 233, 'back'), ('UBERON_0001013', 'adipose tissue', 242, 'spine'), ('UBERON_0004535', 'cardiovascular system', 267, 'cardiovascular'), ('UBERON_0002405', 'immune system', 291, 'immune system'), ('UBERON_0001004', 'respiratory system', 320, 'respiratory')]	0	['materials methods\npublications 25(oh)d concentrations outcomes searchingpubmed.govandscholar.google.comfor terms 25-hydroxyvitamin d, meta-analysis, back spine disorders, cancer, cardiovascular disease, osteoporosis, respiratory infection, economic burden, canada, cost, season, mortality, .']
S190-PMC5129897	PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]	0	['one reduction blood pressure liberating nitric oxide subcutaneous nitrogen stores.101another uv  response psoriasis, asthma, ms, infection mechanisms .102uvb exposure reduces ms –dependent –independent mechanisms.103\nthe regarding skin cancer melanoma burning, uv exposure.']
S114-PMC5240436	PMC5240436	1/2017	S114-PMC5240436	['a PREVIOUS STUDY that provided combined Vitamin A and zinc supplementation to children in ghana LED TO a reduction in the RISK of clinical malaria episodes [46] possibly DUE TO the synergistic EFFECTS of Vitamin A and zinc on Immune function [47].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 170), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A'), ('UBERON_0002405', 'immune system', 226, 'immune')]	0	['combined  zinc supplementation children ghana reduction malaria episodes [46] synergistic  zinc  [47].']
S48-PMC5310660	PMC5310660	1/2017	S48-PMC5310660	['Gestational Vitamin D concentration IS CONSIDERED IMPORTANT for the Development Of the Immune System.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 50)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0002020', 'protease binding', 68, 'development of ... immune system'), ('UBERON_0002405', 'immune system', 87, 'immune system')]	0	['gestational  concentration .']
S182-PMC5332602	PMC5332602	3/2017	S182-PMC5332602	['this is IN AGREEMENT with the uniform suppression of the various innate Immune parameters evaluated in THIS STUDY and ASSOCIATED with protein deficiency versus concurrent up- or downregulation of those in Vitamin A-deficient Pigs (31).']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('UBERON_0002405', 'immune system', 72, 'immune'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 225, 'pigs')]	0	['suppression innate  parameters protein up- downregulation -deficient pigs (31).']
S123-PMC5340372	PMC5340372	3/2017	S123-PMC5340372	['RECENT STUDIES HAVE SHOWN that Vitamin D CAN directly stimulate several Immune Cells and CAN promote the Production Of Antimicrobial Peptides [45–47].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 89)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 72, 'immune cells'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('GO_0008283', 'cell proliferation', 105, 'production of ... peptides'), ('CHEBI_65381', 'albizoside C', 119, 'antimicrobial')]	0	['recent   cells production antimicrobial peptides [45–47].']
S34-PMC5351212	PMC5351212	3/2017	S34-PMC5351212	['developmental Vitamin D deficiency HAS further BEEN shown to induce persistent alterations in Immune function, by increasing central Immune Organ size and inducing a pro-inflammatory Lymphocyte phenotype [32].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('UBERON_0000945', 'stomach', 133, 'immune organ'), ('CL_0000542', 'lymphocyte', 183, 'lymphocyte')]	0	['developmental  alterations  function, central immune organ inducing pro-inflammatory lymphocyte phenotype [32].']
S6-PMC5372327	PMC5372327	3/2017	S6-PMC5372327	['discussion\nthe study ENABLES evaluation of short and long term EFFECTS of supplemental Vitamin D on growth, Immune functions and Skeletal and developmental parameters in infants, and the EFFECTS of Genetic FACTORS therein.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('UBERON_0004288', 'skeleton', 129, 'skeletal'), ('SO_0000704', 'gene', 198, 'genetic')]	0	['discussion\nthe term supplemental  growth,  functions skeletal developmental parameters infants, genetic therein.']
S33-PMC5405075	PMC5405075	4/2017	S33-PMC5405075	['an immunodulatory ROLE of Vitamin D HAS also BEEN DESCRIBED in both Immune System and Lung Cell Maturation, which occurs MAINLY during fetal and early Extrauterine Life (40–42).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 121)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007566', 'embryo implantation', 68, 'immune system'), ('UBERON_0002405', 'immune system', 68, 'immune system'), ('CL_0000175', 'luteal cell', 86, 'lung cell'), ('GO_0060424', 'lung field specification', 86, 'lung cell maturation'), ('UBERON_0002048', 'lung', 86, 'lung'), ('UBERON_0005928', 'external naris', 151, 'extrauterine life')]	0	['immunodulatory   lung cell maturation, occurs fetal extrauterine life (40–42).']
S94-PMC5418719	PMC5418719	5/2017	S94-PMC5418719	['RECENT STUDIES DEMONSTRATED that low Vitamin D PREDISPOSE to increased RISK of rickets, Immune dysfunction, asthma, type 1 diabetes and Viral Respiratory Tract infections during infancy [14–17].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0002405', 'immune system', 88, 'immune'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0000065', 'respiratory tract', 142, 'respiratory tract')]	0	['recent  rickets,  dysfunction, asthma, type diabetes viral respiratory tract infections infancy [14–17].']
S96-PMC5418719	PMC5418719	5/2017	S96-PMC5418719	['moreover, INADEQUATE Vitamin D levels in Cord Blood are ASSOCIATED with Immune status and the prevalence of SEVERE Respiratory Tract infections in the first year of Life, as well as reduced bone density during childhood [18–20].']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0009472', 'axilla', 41, 'cord blood'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('UBERON_0000065', 'respiratory tract', 115, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 165, 'life')]	0	['moreover,  levels cord blood  status respiratory tract infections year life, bone density childhood [18–20].']
S122-PMC5418719	PMC5418719	5/2017	S122-PMC5418719	['the POTENTIAL risk of Vitamin D deficiency on Immune status of preterm infants at Birth has attracted much INTEREST RECENTLY [32].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 46, 'immune'), ('GO_0007567', 'parturition', 82, 'birth')]	0	['  status preterm infants birth attracted [32].']
S2-PMC5489519	PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]	0	['tumor necrosis factor-related apoptosis inducing ligand (trail) cellular growth/apoptosis,  cell bone-resorbing osteoclast formation, expression trail human milk  status mothers unknown.']
S11-PMC5489519	PMC5489519	6/2017	S11-PMC5489519	['in addition, Vitamin D is IMPLICATED in the Regulation of T-Lymphocytes, Monocytes and Macrophages Of the Immune System3–5.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'regulation'), ('CL_0000084', 'T cell', 58, 'T-lymphocytes'), ('CL_0000576', 'monocyte', 73, 'monocytes'), ('CL_0000091', 'Kupffer cell', 87, 'macrophages of ... immune system3'), ('UBERON_0002405', 'immune system', 106, 'immune system3')]	0	['addition,  t-lymphocytes, monocytes macrophages –5.']
S18-PMC5489519	PMC5489519	6/2017	S18-PMC5489519	['THEREFORE, Vitamin D deficient mothers are more LIKELY to have infants with Vitamin D deficiency which AFFECTS Immune and bone health16.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002405', 'immune system', 111, 'immune')]	0	['therefore,  mothers infants   bone health16.']
S20-PMC5489519	PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]	0	['however,  lactating mothers expression cellular factor(s) human milk  skeletal breastfeeding infants.']
S26-PMC5489519	PMC5489519	6/2017	S26-PMC5489519	['SIMILAR to Vitamin D, Trail HAS BEEN SHOWN to Regulate Immune Cell functions, Bone Remodeling and Cell Growth/Differentiation20,22.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 22, 'TRAIL'), ('GO_0065007', 'biological regulation', 46, 'regulate'), ('CL_0000738', 'leukocyte', 55, 'immune cell'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('GO_0046849', 'bone remodeling', 78, 'bone remodeling'), ('GO_0034614', 'cellular response to reactive oxygen species', 98, 'cell growth ... differentiation20')]	0	['similar trail regulate  cell functions, bone remodeling cell growth/differentiation20,22.']
S89-PMC5489519	PMC5489519	6/2017	S89-PMC5489519	['Vitamin D supplementation of mothers results in Vitamin D sufficiency in Breast-Fed infants13, THUS POTENTIALLY Modulating the Immune signature of maternal Breast Milk to her recipient infant.']	[('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0065007', 'biological regulation', 112, 'modulating'), ('UBERON_0002405', 'immune system', 127, 'immune'), ('UBERON_0001348', 'brown adipose tissue', 156, 'breast milk')]	0	['vitamin supplementation mothers results  breast-fed infants13,  maternal breast milk recipient infant.']
S91-PMC5489519	PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]	0	['thus,  altered trail expression breast milk mother infant .']
S106-PMC5489519	PMC5489519	6/2017	S106-PMC5489519	['this evidence SUGGESTS that Vitamin D and Trail Expression in Mammalian cells play a MAJOR ROLE in both mother and infant Immune health.']	[('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 85), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 42, 'TRAIL'), ('GO_0010467', 'gene expression', 48, 'expression'), ('NCBITaxon_40674', 'Mammalia', 62, 'mammalian'), ('UBERON_0002405', 'immune system', 122, 'immune')]	0	[' trail expression mammalian cells play mother infant  health.']
S53-PMC5513133	PMC5513133	7/2017	S53-PMC5513133	['role of Vitamin D as an Anti-Inflammatory Agent and Immune modulator\nVitamin D IS THOUGHT TO play a significant ROLE in pe as an Immune modulator [20,50].']	[('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 112)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_67079', 'anti-inflammatory agent', 24, 'anti-inflammatory agent'), ('UBERON_0002405', 'immune system', 52, 'immune'), ('CHEBI_28384', 'vitamin K', 69, 'Vitamin D'), ('UBERON_0002405', 'immune system', 129, 'immune')]	0	['role  anti-inflammatory agent  modulator\nvitamin play pe  modulator [20,50].']
S91-PMC5513133	PMC5513133	7/2017	S91-PMC5513133	['given the ROLE of Vitamin D in Modulation of inflammation and Immune function, Placental Implantation, Angiogenesis and adverse Birth outcomes such as low Birth weight and sga, we EXAMINED the EVIDENCE that Vitamin D MAY play a ROLE in the etiology and PREVENTION of pe in this manuscript.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 217), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0065007', 'biological regulation', 31, 'modulation'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 79, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('GO_0007566', 'embryo implantation', 89, 'implantation'), ('GO_0001525', 'angiogenesis', 103, 'angiogenesis'), ('GO_0007567', 'parturition', 128, 'birth'), ('GO_0007567', 'parturition', 155, 'birth'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]	0	['given  inflammation  function, placental implantation, angiogenesis birth outcomes birth sga,  play etiology pe manuscript.']
S24-PMC5579643	PMC5579643	8/2017	S24-PMC5579643	['Nutrients, such as zinc and Vitamin D and nutritional factors, such as pre- and Probiotics, CAN INFLUENCE the nature of an Immune Response and are important in ensuring appropriate functioning of the Immune System, as described in the paragraphs below.']	[('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 96)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrients'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_26346', 'prostaglandins J', 80, 'probiotics'), ('GO_0006955', 'immune response', 123, 'immune response'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('UBERON_0002405', 'immune system', 200, 'immune system'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 207, 'system')]	0	['nutrients, zinc  nutritional factors, pre- probiotics, nature  response ensuring functioning paragraphs below.']
S57-PMC5579643	PMC5579643	8/2017	S57-PMC5579643	['HOWEVER, over the last decade, the EFFECTS of Vitamin D on the innate and Adaptive Immune System HAVE BEEN investigated and expanded [20].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051866', 'general adaptation syndrome', 74, 'adaptive immune system'), ('UBERON_0002405', 'immune system', 83, 'immune system')]	0	['however, last decade,  innate adaptive  [20].']
S61-PMC5579643	PMC5579643	8/2017	S61-PMC5579643	['NEVERTHELESS, the POTENTIAL EFFECT of Vitamin D on Th1/Th2 Adaptive Immune Response is of INTEREST and RELATED to Food allergy [21,22,23].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 28), ('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 103)]	5	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0042639', 'telogen', 51, 'Th1 ...'), ('GO_0002290', 'gamma-delta T cell activation involved in immune response', 55, 'Th2 adaptive immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('CHEBI_33290', 'food', 114, 'food')]	0	['nevertheless,  th1/th2 adaptive  response food allergy [21,22,23].']
S62-PMC5579643	PMC5579643	8/2017	S62-PMC5579643	['ALMOST ALL cells Of the Adaptive Immune System Express the Vitamin D receptor, making them also capable of being Vitamin responsive.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CL_1001434', 'olfactory bulb interneuron', 17, 'of ... adaptive immune system'), ('GO_0019825', 'oxygen binding', 24, 'adaptive immune'), ('UBERON_0002405', 'immune system', 33, 'immune system'), ('GO_0010467', 'gene expression', 47, 'express'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 113, 'vitamin')]	0	['almost cells adaptive  express  receptor, capable vitamin responsive.']
S30-PMC5634602	PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]	0	['  function, respiratory health, allergy atopic disease, tissue organ functions becomes apparent, serum 25(oh)d [12–14].']
S0-PMC5638722	PMC5638722	8/2017	S0-PMC5638722	['EFFECTS of Cord Blood Vitamin D levels on the RISK of neonatal sepsis in premature infants\n\nabstract\n\npurpose\nVitamin D plays a KEY ROLE in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('UBERON_0002240', 'spinal cord', 11, 'cord'), ('UBERON_0000178', 'blood', 16, 'blood'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 110, 'Vitamin D'), ('UBERON_0002405', 'immune system', 140, 'immune')]	0	['effects cord blood  levels neonatal sepsis premature infants\n\nabstract\n\npurpose\nvitamin plays  function.']
S141-PMC5659607	PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]	0	['addition, human fertility [29,30], supplementation optimize implantation fertilized egg assure  lung  life.']
S150-PMC5659607	PMC5659607	10/2017	S150-PMC5659607	['it has already been shown that maternal Vitamin D status is ASSOCIATED with OTHER Immune-mediated diseases such as pre-eclampsia[34] and type i diabetes in the offspring[35].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]	0	['maternal  status -mediated diseases pre-eclampsia[34] type diabetes offspring[35].']
S151-PMC5659607	PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]	0	['combining combined analysis,  supplementation childhood asthma/recurrent wheeze,  nutrient -mediated disorders.']
S15-PMC5679631	PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]	0	['given intestinal microbiotic homeostasis  diseases  status factor, postnatal  supplementation older infants.']
S26-PMC5679631	PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]	0	['given  status intestinal microbiotic homeostasis, turn  diseases, maternal multivitamin supplements containing maternal  status (25 hydroxyvitamin (25(oh)d), administration  supplement baby presence abundance bacterial taxa infant gut microbiota.']
S116-PMC5679631	PMC5679631	11/2017	S116-PMC5679631	['we THEORIZED that Vitamin D COULD IMPACT Intestinal colonization due to its immunomodulatory EFFECTS [17,18]; namely, through its inhibition of Intestinal infections via stimulated Antimicrobial Peptide Production and promotion of anti-Inflammatory Responses by the Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 3), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 93)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000160', 'intestine', 41, 'intestinal'), ('UBERON_0000160', 'intestine', 144, 'intestinal'), ('CHEBI_65381', 'albizoside C', 181, 'antimicrobial'), ('GO_0001519', 'peptide amidation', 195, 'peptide production'), ('GO_0006888', 'endoplasmic reticulum to Golgi vesicle-mediated transport', 236, 'inflammatory responses'), ('UBERON_0002405', 'immune system', 266, 'immune system')]	0	[' intestinal colonization immunomodulatory [17,18]; namely, inhibition intestinal infections via antimicrobial peptide production anti-inflammatory responses .']
S129-PMC5679631	PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]	0	['summary,  regulate  response maintain  homeostasis [25] balancing activation tolerance innate .']
S130-PMC5679631	PMC5679631	11/2017	S130-PMC5679631	['ALTHOUGH Vitamin D promotes Immune tolerance, adequate Adaptive Immune Response, as measured by Igg Production in response to infection or vaccination, HAS BEEN observed in patients with relatively high Serum 25(Oh)D levels, SUGGESTING that Vitamin D maintains Immune stability by preventing excessive Immune Responses in EITHER direction [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 225), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 322)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('GO_0002250', 'adaptive immune response', 55, 'adaptive immune response'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('GO_0032608', 'interferon-beta production', 96, 'IgG production'), ('GO_0071735', 'IgG immunoglobulin complex', 96, 'IgG'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('GO_0006955', 'immune response', 302, 'immune responses'), ('UBERON_0002405', 'immune system', 302, 'immune')]	0	['although   tolerance, adaptive  response, igg production response infection vaccination, patients serum 25(oh)d levels,   stability excessive  responses [26].']
S10-PMC5716389	PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]	0	['maternal nutritional status, exposure fetal life nurturing environment, fetal  [3,4], particular, micronutrients zinc, iron,  protein energy malnutrition (pem).']
S31-PMC5716389	PMC5716389	9/2017	S31-PMC5716389	['Micronutrients\nseveral Micronutrients (Minerals or Vitamins) are KNOWN to be IMPORTANT in Fetal Immune System Development and child Immune Response to vaccines.table 1summarizes findings relevant to Immune functioning (zinc, Vitamin A, d, Folate, Iodine and Iron).']	[('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77)]	2	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_33839', 'macromolecule', 23, 'micronutrients'), ('CHEBI_46751', 'quinolizidine', 39, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('UBERON_0000922', 'embryo', 90, 'fetal'), ('GO_0002520', 'immune system development', 96, 'immune system development'), ('UBERON_0002405', 'immune system', 96, 'immune system'), ('GO_0006955', 'immune response', 132, 'immune response'), ('UBERON_0002405', 'immune system', 132, 'immune'), ('UBERON_0002405', 'immune system', 199, 'immune'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 239, 'folate'), ('CHEBI_24859', 'iodine atom', 247, 'iodine'), ('CHEBI_24870', 'ion', 258, 'iron')]	0	['micronutrients\nseveral micronutrients (minerals vitamins) fetal  child  response vaccines.table  functioning (zinc, d, folate, iodine iron).']
S41-PMC5716389	PMC5716389	9/2017	S41-PMC5716389	"['[""""FURTHER, Vitamin A IS NEEDED in the Development and functioning Of the Cell-Mediated and humoral Immune Systems, with deficiency at Birth POTENTIALLY reducing the infant\'s response to vaccines.""""]']"	[('FUTURE_WORK', 0), ('FUTURE_WORK', 19), ('INCOMPLETE_EVIDENCE', 138)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0009566', 'fertilization', 36, 'development ... of ...'), ('GO_0007464', 'R3/R4 cell fate commitment', 71, 'cell-mediated ... immune systems'), ('UBERON_0002405', 'immune system', 97, 'immune systems'), ('GO_0007567', 'parturition', 132, 'birth')]	0	"['[""""furthen functioning cell-mediated humorems, birth reducing infant*s response vaccines.""""]']"
S43-PMC5716389	PMC5716389	9/2017	S43-PMC5716389	['there is NO INFORMATION on the ASSOCIATION between maternal Vitamin A status during Pregnancy and infant Immune Response.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0006955', 'immune response', 105, 'immune response'), ('UBERON_0002405', 'immune system', 105, 'immune')]	0	['maternal  status pregnancy infant  response.']
S13-PMC5827025	PMC5827025	2/2018	S13-PMC5827025	['RECENTLY, Vitamin D is well recognized for its non-classical actions including antioxidant activity, modulation of innate Immune response and Adaptive Immune Response2–4.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0002836', 'positive regulation of response to tumor cell', 142, 'adaptive immune response2'), ('UBERON_0002405', 'immune system', 151, 'immune')]	0	['recently,  antioxidant activity, innate  response adaptive  response2–4.']
S354-PMC5941617	PMC5941617	5/2018	S354-PMC5941617	['RECENTLY, litonjua SHOWED that Vitamin D has both in utero and post-Natal EFFECTS on Lung Development and Immune System Development and function [304].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 74)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'natal'), ('GO_0030324', 'lung development', 85, 'lung development'), ('UBERON_0002048', 'lung', 85, 'lung'), ('GO_0002520', 'immune system development', 106, 'immune system development'), ('UBERON_0002405', 'immune system', 106, 'immune system')]	0	['recently, litonjua  utero post-natal lung  [304].']
S459-PMC5941617	PMC5941617	5/2018	S459-PMC5941617	['it HAS BEEN SUGGESTED that early-Life Vitamin D deficiency MAY CONTRIBUTE to the pathogenesis of childhood-onset cd by determining inappropriate Immune Responses, abnormal Intestinal Mucosal integrity and impaired local Defence against Microbial agents [413].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0000104', 'life cycle', 33, 'life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0006955', 'immune response', 145, 'immune responses'), ('UBERON_0002405', 'immune system', 145, 'immune'), ('UBERON_0001262', 'wall of intestine', 172, 'intestinal mucosal'), ('GO_0006952', 'defense response', 220, 'defence'), ('NCBITaxon_10088', 'Mus <genus>', 236, 'microbial')]	0	['early-life  pathogenesis childhood-onset cd  responses, abnormal intestinal mucosal integrity local defence microbial agents [413].']
S14-PMC5952272	PMC5952272	5/2018	S14-PMC5952272	['approximately 1 in 68 children aged 8\u2009years living in sites participating in the addm network surveillance areas (usa) met the asd case criteria for the 2012 surveillance year.1some HYPOTHESES were SUGGESTED to explain this increase, such as an increased awareness, improved detection, expanding definition, or an actual increase in incidence or a combination of these FACTORS.2ALTHOUGH both Genetic and multiple environmental RISK FACTORS HAVE BEEN studied extensively, many POTENTIALLY modifiable RISK factors including nutritional and Immune function–RELATED RISK FACTORS such as Vitamin D, Folic Acid, and Metabolic syndrome have NOT RECEIVED SUFFICIENT ATTENTION.3SEVERAL RECENT STUDIES have put FORWARD hypotheses to explain the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 198), ('SUPERFICIAL_RELATIONSHIP', 369), ('ANOMALY_CURIOUS_FINDING', 377), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 440), ('INCOMPLETE_EVIDENCE', 476), ('SUPERFICIAL_RELATIONSHIP', 499), ('SUPERFICIAL_RELATIONSHIP', 554), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 634), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 668), ('INCOMPLETE_EVIDENCE', 677), ('FUTURE_WORK', 701), ('SUPERFICIAL_RELATIONSHIP', 748)]	15	[('SO_0000704', 'gene', 392, 'genetic'), ('UBERON_0002405', 'immune system', 538, 'immune'), ('CHEBI_27300', 'vitamin D', 583, 'vitamin D'), ('CHEBI_30751', 'formic acid', 594, 'folic acid'), ('GO_0008152', 'metabolic process', 610, 'metabolic'), ('CHEBI_30751', 'formic acid', 773, 'folic acid'), ('CHEBI_27300', 'vitamin D', 788, 'vitamin D')]	0	['approximately 68 children aged 8\u2009years living sites participating addm (usa) met asd criteria 2012 year.1some increase, awareness, detection, definition, actual increase combination factors.2although genetic environmental extensively, nutritional  function–related folic acid, metabolic syndrome received attention.3several folic acid  autism.']
S147-PMC5952272	PMC5952272	5/2018	S147-PMC5952272	['experiment on Animal models SHOWED that 1,25 Dihydroxyvitamin D3 Prenatal supplementations were PROTECTIVE for offsprings against induced Maternal Immune Activation (mia).42maternal Immune Activation in experimental Animals Reproduces asd-like symptoms via significant increase of proinflammatory cytokines; however, administration of Vitamin D has blocked the emergence of asd-relevant deficits in social INTERACTION, stereotyped behaviour, and emotional Learning and Memory.42RECENTLY, sotodehasl et al43have reviewed 80 articles LINKING autism and Vitamin D. the authors found no significant DIFFERENCES between children with asd and neurotypical developed children.43this was also SUPPORTED by a canadian prospective cohort study that included 3852 children.44forty-one children were diagnosed with asd, who have no difference in the level of Vitamin D in their Serum compared with non-asd children.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 406), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 476), ('SUPERFICIAL_RELATIONSHIP', 532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 685)]	7	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 40, '1,25 dihydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 62, 'D3'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007618', 'mating', 138, 'maternal'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 147, 'immune activation'), ('UBERON_0002405', 'immune system', 147, 'immune'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 182, 'immune activation'), ('UBERON_0002405', 'immune system', 182, 'immune'), ('NCBITaxon_33208', 'Metazoa', 216, 'animals'), ('GO_0000003', 'reproduction', 224, 'reproduces'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('GO_0007612', 'learning', 456, 'learning'), ('GO_0007613', 'memory', 469, 'memory'), ('CHEBI_27300', 'vitamin D', 551, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 847, 'vitamin D'), ('UBERON_0001977', 'blood serum', 866, 'serum')]	0	['experiment animal 1,25 dihydroxyvitamin d3 prenatal supplementations offsprings induced maternal  activation (mia).42maternal  activation animals asd-like symptoms via increase proinflammatory cytokines; however, administration  blocked asd-relevant social interaction, behaviour, emotional learning memory.42recently, sotodehasl et al43have 80 articles autism . authors children asd neurotypical children.43this 3852 children.44forty-one children diagnosed asd,  serum non-asd children.']
S15-PMC5956785	PMC5956785	5/2018	S15-PMC5956785	['AS an Immune and inflammatory Mediator, Vitamin D is IMPLICATED in the pathogenesis of Autoimmune diseases including, as examples, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, crohn’s disease, and chronic childhood arthritis [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002405', 'immune system', 6, 'immune'), ('CHEBI_35222', 'inhibitor', 30, 'mediator'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 87, 'autoimmune')]	0	[' inflammatory mediator,  pathogenesis autoimmune diseases including, examples, sclerosis, type diabetes, rheumatoid arthritis, crohn’s disease, chronic childhood arthritis [4–6].']
S210-PMC5956785	PMC5956785	5/2018	S210-PMC5956785	['additionally, IMPROVED UNDERSTANDING of Vitamin D NEEDS in children with chronic arthritis will HELP TO CLARIFY the ROLE of Vitamin D in the UNDERLYING disease processes so that therapies that target specific Vitamin D responsive Immune pathways CAN be developed.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 23), ('FUTURE_WORK', 50), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 141), ('FUTURE_WORK', 246), ('INCOMPLETE_EVIDENCE', 246)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0002405', 'immune system', 230, 'immune')]	0	['additionally,  children chronic arthritis  disease processes therapies  responsive  developed.']
